https://curecurrent.com/trials/a-pilot-study-to-explore-the-role-of-gut-flora-in-rheumatoid-arthritis-101006https://curecurrent.com/trials/a-study-to-learn-about-the-study-medicine-called-infliximab-genetical-recombination-infliximab-biosimilar-3-in-people-wi-101007https://curecurrent.com/trials/therapy-of-niacin-for-rheumatoid-arthritis-101008https://curecurrent.com/trials/rheumatoid-arthritis-synovial-tissue-biopsy-study-101009https://curecurrent.com/trials/occupational-and-environmental-causes-of-autoimmune-diseases-101010https://curecurrent.com/trials/medical-follow-up-of-new-cases-of-polyarthritis-in-children-and-young-adults-101011https://curecurrent.com/trials/tapering-of-rituximab-based-on-interval-prolongation-compared-to-disease-activity-guided-dose-reduction-in-patients-with-101012https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-asp015k-in-moderate-to-severe-rheumatoid-arthritis-subjects-who-have-had-101013https://curecurrent.com/trials/a-study-of-jnj-67484703-in-participants-with-active-rheumatoid-arthritis-101014https://curecurrent.com/trials/clinical-study-on-the-treatment-of-refractory-rheumatoid-arthritis-with-utaa91-injection-101015https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-or3o-dual-mobility-system-vs-conventional-single-bearing-design-total-hip-s-101016https://curecurrent.com/trials/neuropathic-hand-pain-in-rheumatoid-arthritis-101017https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-asp015k-in-moderate-to-severe-rheumatoid-arthritis-101018https://curecurrent.com/trials/assessing-pain-by-the-paindetect-questionnaire-pdq-101019https://curecurrent.com/trials/efficacy-and-safety-of-telitacicept-combined-with-tofacitinib-for-refractory-rheumatoid-arthritis-101020https://curecurrent.com/trials/app-based-education-and-goal-setting-in-rheumatoid-arthritis-101021https://curecurrent.com/trials/a-prospective-pre-market-multi-center-study-of-insignia-hip-stem-in-tha-to-determine-implant-survivorship-and-proms-101022https://curecurrent.com/trials/ultrasound-to-guide-treatment-decisions-in-patients-with-rheumatoid-arthritis-according-to-a-t2t-approach-101023https://curecurrent.com/trials/early-clinical-study-of-utaa91-injection-for-the-treatment-of-relapsed-refractory-autoimmune-diseases-101024https://curecurrent.com/trials/could-a-feedback-device-help-manage-work-related-shoulder-disorders-101025https://curecurrent.com/trials/the-medacta-international-amistem-p-post-marketing-surveillance-study-101026https://curecurrent.com/trials/a-study-on-the-effectiveness-of-ankle-dorsiflexion-range-of-motion-training-in-patients-with-patellofemoral-joint-pain-101027https://curecurrent.com/trials/covid-19-vaccine-response-in-rheumatology-patients-101028https://curecurrent.com/trials/limbal-stem-cell-derived-exosome-lsc-exo-eye-drop-for-treatment-of-dry-eye-101029https://curecurrent.com/trials/effect-of-subcutaneous-polyvidone-collagen-treatment-on-hand-recovery-in-adult-rheumatoid-arthritis-101030https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-vib4920-in-participants-with-sj-gren-s-syndrome-101031https://curecurrent.com/trials/an-exploratory-clinical-study-of-cd19-car-nk-cells-for-the-treatment-of-refractory-antisynthetase-antibody-syndrome-and-101032https://curecurrent.com/trials/an-observational-study-to-assess-the-real-world-effectiveness-of-upadacitinib-in-adult-participants-with-rheumatoid-arth-101033https://curecurrent.com/trials/food-trial-to-evaluate-the-kinetics-of-the-medical-foods-sbd111-and-sbd121-persistence-in-healthy-adults-101034https://curecurrent.com/trials/biologic-treatment-registry-across-canada-101035https://curecurrent.com/trials/a-study-of-iguratimod-in-combination-with-tofacitinib-in-ra-patients-101036https://curecurrent.com/trials/effect-of-diosmin-and-hesperidin-in-treatment-of-patients-with-rheumatoid-arthritis-101037https://curecurrent.com/trials/an-exploratory-clinical-study-of-scar02-targeting-bcma-and-cd19-for-the-treatment-of-refractory-autoimmune-diseases-101038https://curecurrent.com/trials/phase-2b-study-of-mbs2320-in-participants-with-methotrexate-refractory-ra-101039https://curecurrent.com/trials/nonsurgical-periodontal-treatment-combined-with-anti-tnf-in-patients-with-rheumatoid-arthritis-and-periodontitis-101040https://curecurrent.com/trials/filling-bone-erosions-a-longitudinal-multicentric-hr-pqct-study-of-subcutaneous-tocilizumab-in-rheumatoid-arthritis-101041https://curecurrent.com/trials/remote-care-in-people-with-rheumatoid-arthritis-101042https://curecurrent.com/trials/a-study-of-gnc-038-tetra-specific-antibody-injection-in-patients-with-rheumatoid-arthritis-101043https://curecurrent.com/trials/effect-of-transcutaneous-auricular-electroacupuncture-on-sleep-disturbances-in-patients-with-rheumatoid-arthritis-a-rand-101044https://curecurrent.com/trials/a-study-of-oral-upadacitinib-tablets-to-assess-treatment-patterns-achievement-of-treatment-targets-and-maintenance-of-re-101045https://curecurrent.com/trials/consortium-of-early-arthritis-cohorts-usa-101046https://curecurrent.com/trials/ultra-processed-foods-consumption-and-impact-in-rheumatic-diseases-101047https://curecurrent.com/trials/cellular-and-molecular-analysis-of-synovial-tissue-of-patients-with-arthritis-101048https://curecurrent.com/trials/new-generation-igra-in-immunocompromised-individuals-101049https://curecurrent.com/trials/aylo-autoimmunity-and-loss-of-y-101050https://curecurrent.com/trials/laser-acupuncture-on-dry-eye-and-sj-gren-s-syndrome-related-dry-eye-symptoms-ladesjs-101051https://curecurrent.com/trials/armenian-nationwide-registry-of-systemic-autoimmune-and-autoinflammatory-diseases-101052https://curecurrent.com/trials/safety-of-cultured-allogeneic-adult-umbilical-cord-derived-mesenchymal-stem-cell-intravenous-infusion-for-ra-101053https://curecurrent.com/trials/changes-of-depression-after-first-year-of-tofacitinib-in-ra-patients-101054https://curecurrent.com/trials/changes-in-mtx-pg-concentrations-during-subcutaneous-mtx-therapy-in-patients-with-rheumatoid-arthritis-cosmos-study-101055https://curecurrent.com/trials/investigating-the-effects-of-the-digital-app-rheumabuddy4-1-in-a-clinical-rct-set-up-in-patients-with-rheumatoid-arthrit-101056https://curecurrent.com/trials/phase-i-clinical-study-of-zl-82-tablets-101057https://curecurrent.com/trials/bcma-cd19-car-t-therapy-for-refractory-autoimmune-diseases-101058https://curecurrent.com/trials/evaluate-e1-wear-clinical-performance-of-e1-liner-in-tha-in-korean-patient-population-101059https://curecurrent.com/trials/workwell-testing-work-advice-for-people-with-arthritis-101060https://curecurrent.com/trials/impact-of-cannabis-on-pain-and-inflammation-among-patients-with-rheumatoid-or-psoriatic-arthritis-101061https://curecurrent.com/trials/the-ccp-study-coordinated-programme-to-prevent-arthritis-can-we-identify-arthritis-at-a-pre-clinical-stage-101062https://curecurrent.com/trials/weight-loss-and-exercise-to-improve-rheumatoid-arthritis-cardiovascular-risk-101063https://curecurrent.com/trials/music-therapy-model-the-bonny-method-of-guided-imagery-and-music-on-patients-with-rheumatoid-arthritis-101064https://curecurrent.com/trials/postprandial-inflammation-in-rheumatoid-arthritis-101065https://curecurrent.com/trials/prognostic-evaluation-of-inflammatory-polyarthritis-of-recent-onset-101066https://curecurrent.com/trials/mesenchymal-stem-cells-infusion-in-patients-with-autoimmune-diseases-101067https://curecurrent.com/trials/safety-study-of-abatacept-to-treat-rheumatoid-arthritis-101068https://curecurrent.com/trials/exercise-training-and-knee-joint-proprioception-in-rheumatoid-arthritis-101069https://curecurrent.com/trials/combining-virtual-reality-and-hypnosis-to-alleviate-chronic-pain-in-elderly-patients-with-hand-arthritis-101070https://curecurrent.com/trials/predictive-utility-of-a-short-term-improvement-in-objectively-measured-physical-activity-in-rheumatoid-arthritis-pusipa-101071https://curecurrent.com/trials/core-stabilization-strenght-and-pelvic-floor-functions-in-primary-sjogren-s-101072https://curecurrent.com/trials/cross-validation-of-a-predictive-model-of-response-to-anti-tnf-alpha-based-on-oxylipin-response-in-rheumatoid-arthritis-101073https://curecurrent.com/trials/an-observational-study-to-assess-the-impact-of-upadacitinib-in-adult-hungarian-participants-with-moderate-to-severe-rheu-101074https://curecurrent.com/trials/evaluation-of-spironolactone-efficacy-in-patient-with-rheumatoid-arthritis-ra-101075https://curecurrent.com/trials/clinical-trial-evaluating-methotrexate-or-leflunomide-targeted-therapy-versus-methotrexate-or-leflunomide-sulfasalazine-101076https://curecurrent.com/trials/assessment-of-physician-consideration-of-epro-s-from-patients-with-gout-rheumatoid-arthritis-sjogren-s-syndrome-or-syste-101077https://curecurrent.com/trials/ro60-expression-in-macrophages-in-sjogren-s-disease-101078https://curecurrent.com/trials/long-term-outcomes-of-patients-with-rheumatoid-arthritis-in-remission-101079https://curecurrent.com/trials/prediction-of-abatacept-discontinuation-using-test-reflecting-immunological-remission-in-rheumatoid-arthritis-101080https://curecurrent.com/trials/study-to-evaluate-safety-and-efficacy-of-ccx-354-c-in-subjects-with-rheumatoid-arthritis-101081https://curecurrent.com/trials/the-oxylipin-response-as-a-new-predictive-biomarker-of-patient-responsiveness-to-biotherapy-in-rheumatoid-arthritis-oper-101082https://curecurrent.com/trials/evaluation-of-the-optimal-mtx-dose-as-an-add-on-therapy-to-adalimumab-for-ra-patients-in-japan-south-korea-and-taiwan-101083https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-ccx354-c-in-subjects-with-rheumatoid-arthritis-partially-responsive-to-me-101084https://curecurrent.com/trials/construct-validity-and-responsiveness-of-eq-5d-3l-in-patients-with-rheumatic-disease-101085https://curecurrent.com/trials/a-study-of-anakinra-in-japanese-patients-with-still-s-disease-sjia-and-aosd-101086https://curecurrent.com/trials/the-relationship-of-hand-sensory-and-strength-assessments-with-functionality-and-kinesiophobia-in-individuals-with-rheum-101087https://curecurrent.com/trials/an-extension-study-of-ts-152-in-subjects-with-rheumatoid-arthritis-101088https://curecurrent.com/trials/safety-and-efficacy-of-swk002-in-patients-with-d2t-rheumatoid-arthritis-101089https://curecurrent.com/trials/elector-treat-to-target-via-home-based-disease-activity-monitoring-of-patients-with-rheumatoid-arthritis-101090https://curecurrent.com/trials/methotrexate-blood-pressure-and-arterial-function-in-rheumatoid-arthritis-101091https://curecurrent.com/trials/an-alternative-assessment-in-patients-with-rheumatoid-arthritis-6-minute-step-test-101092https://curecurrent.com/trials/effects-of-abatacept-on-the-progression-to-rheumatoid-arthritis-palaba-study-101093https://curecurrent.com/trials/smr-stemless-shoulder-arthroplasty-clinical-study-101094https://curecurrent.com/trials/partial-synovectomy-in-articular-side-of-quadriceps-tendon-verified-to-reduce-crepitus-in-retrospective-study-101095https://curecurrent.com/trials/a-clinical-study-of-tqh3821-tablets-in-the-treatment-of-treated-rheumatoid-arthritis-101096https://curecurrent.com/trials/a-study-to-compare-the-response-to-treatment-with-abatacept-vs-adalimumab-on-background-methotrexate-in-adults-with-earl-101097https://curecurrent.com/trials/a-phase-1b-study-of-imvotamab-in-moderate-to-severe-rheumatoid-arthritis-101098https://curecurrent.com/trials/infinity-total-ankle-replacement-follow-up-101099https://curecurrent.com/trials/investigation-of-muscle-oxygenation-in-patients-with-rheumatoid-arthritis-101100https://curecurrent.com/trials/tolerance-and-efficacy-of-rituximab-in-sjogren-s-disease-101101https://curecurrent.com/trials/tolerance-and-efficiency-of-an-intrabuccal-biological-film-to-enhance-oral-dryness-sensation-the-predelfi-clinical-pilot-101102https://curecurrent.com/trials/intraglandular-treatment-with-adipose-derived-mesenchymal-stem-cells-in-patients-with-xerostomia-due-to-sj-gren-s-diseas-101103https://curecurrent.com/trials/analysis-of-birth-outcomes-of-swedish-danish-and-finnish-women-exposed-to-remicade-with-inflammatory-bowel-disease-rheum-101104https://curecurrent.com/trials/clinical-interpretation-and-cutoff-scores-for-abilhand-questionnaire-in-rheumatoid-arthritis-101105https://curecurrent.com/trials/poly-l-d-lactide-implant-regjoint-versus-tendon-interposition-for-trapeziometacarpal-inflammatory-arthritis-a-15-year-fo-101106https://curecurrent.com/trials/a-study-to-assess-the-safety-and-efficacy-of-ecf843-vs-vehicle-in-subjects-with-dry-eye-disease-101107https://curecurrent.com/trials/otis-cimzia-pregnancy-registry-101108https://curecurrent.com/trials/relation-between-pulmonary-function-tests-and-ultrasonographic-chest-joints-101109https://curecurrent.com/trials/otis-humira-pregnancy-registry-101110https://curecurrent.com/trials/n-acetylcysteine-for-primary-sj-gren-s-syndrome-101111https://curecurrent.com/trials/exactech-humeral-reconstruction-prosthesis-of-shoulder-arthroplasty-pmcf-hrp-101112https://curecurrent.com/trials/efficacy-and-safety-study-comparing-cpl409116-to-placebo-in-participants-with-active-rheumatoid-arthritis-101113https://curecurrent.com/trials/tc-99m-tilmanocept-imaging-for-early-prediction-of-anti-tnf-therapy-response-in-moderate-to-severe-active-ra-101114https://curecurrent.com/trials/observational-study-in-patients-treated-with-jak-inhibitors-for-inflammatory-rheumatism-majik-101115https://curecurrent.com/trials/screening-anxiety-and-depression-among-patients-with-chronic-musculoskeletal-pain-within-physiotherapy-practices-101116https://curecurrent.com/trials/arcos-revision-stem-evaluation-of-clinical-performance-101117https://curecurrent.com/trials/association-between-methotrexate-erythrocyte-polyglutamate-concentration-and-biological-drug-concentration-and-clinical-101118https://curecurrent.com/trials/post-marketing-re-evaluation-of-wangbi-granules-for-rheumatoid-arthritis-101119https://curecurrent.com/trials/biomarkers-in-inflammatory-rheumatic-diseases-diagnosis-101120https://curecurrent.com/trials/exosomes-proteomic-for-sjogren-s-syndrome-and-dry-eye-syndrome-101121https://curecurrent.com/trials/an-observational-study-on-sarilumab-exposed-pregnancies-101122https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-phase-ii-clinical-study-to-evaluate-the-safety-tolerability-efficacy-and-ph-101123https://curecurrent.com/trials/natrunix-or-placebo-in-combination-with-methotrexate-in-rheumatoid-arthritis-101124https://curecurrent.com/trials/differences-in-corneal-structure-and-function-in-patients-with-sjogrens-vs-non-sjogrens-dry-eye-101125https://curecurrent.com/trials/methotrexate-in-patients-with-early-rheumatoid-arthritis-101126https://curecurrent.com/trials/experimental-medicine-studies-of-the-brain-in-patients-with-rheumatoid-arthritis-realise-101127https://curecurrent.com/trials/7-tesla-mri-brain-imaging-to-decipher-filgotinib-s-mode-of-analgesic-action-in-rheumatoid-arthritis-101128https://curecurrent.com/trials/wright-foot-ankle-post-market-observational-study-101129https://curecurrent.com/trials/effects-of-a-mobile-application-ra-joint-protection-and-activity-self-management-program-101130https://curecurrent.com/trials/jakpot-jak-inhibitors-and-predictors-of-outcome-in-rheumatoid-arthritis-101131https://curecurrent.com/trials/comparison-of-tc-99m-tilmanocept-imaging-with-ihc-analysis-of-cd206-expression-in-synovial-tissue-of-subjects-with-ra-101132https://curecurrent.com/trials/development-of-a-normative-database-for-rheumatoid-arthritis-ra-imaging-with-tc99m-tilmanocept-101133https://curecurrent.com/trials/l-carnitine-supplementation-in-rheumatoid-arthritis-patients-101134https://curecurrent.com/trials/vitamin-d-supplementation-on-outcome-and-disease-activity-101135https://curecurrent.com/trials/the-triad-of-nutrition-intestinal-microbiota-and-rheumatoid-arthritis-tasty-101136https://curecurrent.com/trials/nexgen-tm-tibia-clinical-outcomes-study-101137https://curecurrent.com/trials/dental-and-periodontal-status-of-patients-with-sj-gren-s-syndrome-101138https://curecurrent.com/trials/a-phase-1b-study-of-medi4920-in-participants-with-adult-onset-rheumatoid-arthritis-101139https://curecurrent.com/trials/pmcf-study-on-the-safety-performance-and-clinical-benefits-data-of-the-nexgen-tm-augmentation-patella-101140https://curecurrent.com/trials/automated-arthritis-detection-using-artificial-intelligence-on-smartphone-photographs-101141https://curecurrent.com/trials/home-based-clinical-management-of-interstitial-lung-disease-in-systemic-rheumatic-diseases-101142https://curecurrent.com/trials/safety-study-of-hzt-501-in-patients-who-require-long-term-daily-non-steroidal-anti-inflammatory-drug-treatment-101143https://curecurrent.com/trials/a-non-interventional-study-of-rayos-in-adult-patients-with-rheumatoid-arthritis-101144https://curecurrent.com/trials/the-feasibility-of-multispectral-optoacoustic-tomography-in-different-diseases-101145https://curecurrent.com/trials/study-to-assess-the-safety-and-efficacy-of-modified-release-prednisone-lodotra-therapy-in-patients-with-active-rheumatoi-101146https://curecurrent.com/trials/mulligan-mobilization-in-rheumatoid-hand-101147https://curecurrent.com/trials/double-blind-follow-on-safety-study-of-hzt-501-ibuprofen-800-mg-famotidine-26-6-mg-in-subjects-who-have-completed-partic-101148https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-efficacy-of-vib4920-in-participants-with-rheumatoid-arthritis-101149https://curecurrent.com/trials/cardiovascular-risk-factors-in-rheumatoid-arthritis-patients-comparison-between-seronegative-and-seropositive-cases-101150https://curecurrent.com/trials/the-medacta-international-gmk-sphere-post-marketing-surveillance-study-101151https://curecurrent.com/trials/efficacy-and-safety-study-of-hzt-501-in-reducing-the-risk-of-ibuprofen-associated-ulcers-101152https://curecurrent.com/trials/efficacy-and-safety-study-of-hzt-501-in-subjects-requiring-nonsteroidal-anti-inflammatory-drug-nsaid-treatment-101153https://curecurrent.com/trials/a-study-to-evaluate-vib7734-in-participants-with-systemic-lupus-erythematosus-sle-cutaneous-lupus-erythematosus-cle-sjog-101154https://curecurrent.com/trials/a-phase-1-study-of-medi7734-in-type-i-interferon-mediated-autoimmune-diseases-101155https://curecurrent.com/trials/efficacy-confirmation-study-of-cdp870-in-early-rheumatoid-arthritis-101156https://curecurrent.com/trials/effect-of-silymarin-in-rheumatoid-arthritis-patients-treated-with-methotrexate-101157https://curecurrent.com/trials/manual-diaphragmatic-release-on-ventilatory-functions-in-women-with-rheumatoid-arthritis-101158https://curecurrent.com/trials/rheumatology-diet-study-101159https://curecurrent.com/trials/impact-of-bone-mineral-density-on-fracture-risk-assessment-in-ra-101160https://curecurrent.com/trials/impact-of-vitamin-d-in-rheumatoid-arthritis-101161https://curecurrent.com/trials/patient-outcomes-real-world-evidence-in-rheumatoid-arthritis-power-101162https://curecurrent.com/trials/salivary-conductivity-screening-for-dry-eye-disease-and-sj-gren-s-syndrome-101163https://curecurrent.com/trials/metasul-monoblock-component-cup-in-a-hip-resurfacing-application-with-the-durom-hip-resurfacing-femoral-component-101164https://curecurrent.com/trials/advanced-therapeutics-in-rheumatoid-arthritis-ra-101165https://curecurrent.com/trials/emdr-for-persistent-pain-in-ra-101166https://curecurrent.com/trials/evolution-and-treatments-of-chronic-inflammatory-systemic-diseases-101167https://curecurrent.com/trials/an-observational-study-to-evaluate-safety-and-efficacy-of-remsima-in-patients-with-ra-101168https://curecurrent.com/trials/rheum-home-ra-remote-patient-monitoring-101169https://curecurrent.com/trials/biodistribution-dosimetry-and-performance-of-68ga-ga-dota-siglec-9-in-healthy-and-patients-with-rheumatoid-arthritis-vas-101170https://curecurrent.com/trials/a-study-of-efficacy-and-safety-of-rosnilimab-in-subjects-with-moderate-to-severe-rheumatoid-arthritis-renoir-101171https://curecurrent.com/trials/a-clinical-study-to-assess-the-efficacy-of-cannabigerol-in-patients-with-active-rheumatoid-arthritis-101172https://curecurrent.com/trials/universal-car-t-cells-brl-301-in-relapse-or-refractory-autoimmune-diseases-101173https://curecurrent.com/trials/supporting-patient-care-with-electronic-resources-in-the-united-states-101174https://curecurrent.com/trials/mussels-inflammation-and-rheumatoid-arthritis-mira-101175https://curecurrent.com/trials/to-evaluate-the-blood-levels-and-safety-of-iv-and-subcutaneous-cdp6038-in-subjects-with-rheumatoid-arthritis-using-metho-101176https://curecurrent.com/trials/efficacy-and-safety-clinical-study-of-rph-104-in-adult-onset-still-s-disease-aosd-101177https://curecurrent.com/trials/clinical-evaluation-of-integra-cadence-total-ankle-system-in-primary-ankle-joint-replacement-cadence-101178https://curecurrent.com/trials/ultrasonic-comparison-of-salivary-glands-in-autoimmune-diseases-cougar-101179https://curecurrent.com/trials/a-dose-range-study-of-the-safety-and-efficacy-of-treatment-in-adult-rheumatoid-arthritis-patients-with-an-inadequate-res-101180https://curecurrent.com/trials/sequential-car-t-cells-targeting-bcma-cd19-in-patients-with-relapsed-refractory-autoimmune-diseases-101181https://curecurrent.com/trials/nasal-spray-study-in-sjogren-s-dry-eye-disease-101182https://curecurrent.com/trials/fitmore-hip-stem-pmcf-study-a-multi-centre-non-comparative-prospective-post-market-clinical-follow-up-study-101183https://curecurrent.com/trials/diet-and-rheumatoid-arthritis-risk-in-the-united-kingdom-women-s-cohort-101184https://curecurrent.com/trials/a-study-to-assess-the-safety-tolerability-and-pharmacokinetics-of-asp5094-following-multiple-intravenous-doses-in-subjec-101185https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-asp5094-in-patients-with-rheumatoid-arthritis-on-methotrexate-101186https://curecurrent.com/trials/a-study-comparing-biologics-methotrexate-with-biologics-tacrolimus-in-patients-with-rheumatoid-arthritis-ra-101187https://curecurrent.com/trials/a-study-to-evaluate-efficacy-and-safety-of-asp015k-in-patients-with-rheumatoid-arthritis-ra-who-had-an-inadequate-respon-101188https://curecurrent.com/trials/a-study-to-continue-asp015k-treatment-to-rheumatoid-arthritis-patients-who-completed-phase-iib-study-or-phase-iii-study-101189https://curecurrent.com/trials/a-study-to-evaluate-safety-and-efficacy-of-asp015k-in-patients-with-rheumatoid-arthritis-ra-who-had-an-inadequate-respon-101190https://curecurrent.com/trials/tofacitinib-xeljanz-special-investigation-for-rheumatoid-arthritis-101191https://curecurrent.com/trials/incorporating-pro-data-into-ra-clinical-encounters-using-health-it-101192https://curecurrent.com/trials/scintigraphy-for-prediction-in-rheumatoid-intentional-therapy-tapering-101193https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-asp1707-in-postmenopausal-female-patients-with-rheumatoid-arthritis-takin-101194https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-of-asp1707-and-methotrexate-in-patients-with-rheumatoid-arthritis-101195https://curecurrent.com/trials/observational-study-to-determine-how-physicians-make-treatment-decisions-in-patients-treated-with-tofacitinib-for-modera-101196https://curecurrent.com/trials/a-study-to-evaluate-the-long-term-safety-and-efficacy-of-asp015k-in-subjects-previously-enrolled-in-a-phase-2-asp015k-rh-101197https://curecurrent.com/trials/a-study-to-assess-safety-and-efficacy-of-asp015k-in-participants-with-rheumatoid-arthritis-ra-who-had-an-inadequate-resp-101198https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-asp015k-in-moderate-to-severe-rheumatoid-arthritis-subjects-101199https://curecurrent.com/trials/a-drug-interaction-study-to-evaluate-the-pharmacokinetics-of-asp015k-and-methotrexate-in-patients-with-rheumatoid-arthri-101200https://curecurrent.com/trials/the-possible-efficacy-and-protective-effect-of-empagliflozin-in-rheumatoid-arthritis-patients-treated-with-methotrexate-101201https://curecurrent.com/trials/the-effect-of-nicotinamide-on-the-clinical-outcome-of-rheumatoid-arthritis-patients-101202https://curecurrent.com/trials/the-efficacy-and-safety-of-iguratimod-igu-in-the-treatment-of-primary-sj-gren-s-syndrome-101203https://curecurrent.com/trials/fourth-gen-car-t-cells-targeting-bcma-cd19-for-refractory-systemic-lupus-erythematosus-sle-101204https://curecurrent.com/trials/step-up-and-step-down-therapeutic-strategies-in-childhood-arthritis-101205https://curecurrent.com/trials/adira-anti-inflammatory-diet-in-rheumatoid-arthritis-101206https://curecurrent.com/trials/rare-autoimmune-self-management-programme-development-101207https://curecurrent.com/trials/a-study-to-investigate-safety-tolerability-and-pk-of-oral-doses-of-tck-276-in-patients-with-rheumatoid-arthritis-101208https://curecurrent.com/trials/assessment-of-interstitial-lung-disease-in-rheumatoid-arthritis-by-lung-ultrasound-101209https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-efficacy-of-mhv370-in-participants-with-sjogren-s-syndrome-sjs-or-mixed-101210https://curecurrent.com/trials/in-vivo-wear-behaviour-of-as-coated-versus-uncoated-columbus-total-knee-prosthesis-101211https://curecurrent.com/trials/efficacy-of-upadacitinib-in-psoriatic-arthritis-and-comparison-to-rheumatoid-arthritis-101212https://curecurrent.com/trials/health-promotion-of-people-with-disabilities-101213https://curecurrent.com/trials/a-study-to-describe-the-use-of-tofacitinib-after-use-of-rituximab-in-patients-with-rheumatoid-arthritis-in-a-real-world-101214https://curecurrent.com/trials/study-to-evaluate-adverse-events-and-change-in-disease-activity-in-participants-between-18-to-75-years-of-age-treated-wi-101215https://curecurrent.com/trials/a-study-to-compare-efficacy-and-safety-of-ct-p47-and-roactemra-in-patients-with-rheumatoid-arthritis-101216https://curecurrent.com/trials/study-of-baricitinib-a-jak1-2-inhibitor-in-chronic-graft-versus-host-disease-after-allogeneic-hematopoietic-stem-cell-tr-101217https://curecurrent.com/trials/10-year-follow-up-of-patients-with-rheumatoid-arthritis-who-received-structured-treat-to-target-therapy-in-early-disease-101218https://curecurrent.com/trials/comparative-multicenter-study-in-subjects-with-rheumatoid-arthritis-alvoflex-101219https://curecurrent.com/trials/adipose-derived-biocellular-regenerative-therapy-for-osteoarthritis-101220https://curecurrent.com/trials/the-effect-of-the-ideal-food-pyramid-on-rheumatoid-arthritis-101221https://curecurrent.com/trials/identification-of-factors-predictive-of-tofacitinib-s-survival-in-patient-with-rheumatoid-arthritis-101222https://curecurrent.com/trials/musculoskeletal-ultrasound-with-elastography-in-the-evaluation-of-muscle-state-in-rheumatoid-arthritis-patients-101223https://curecurrent.com/trials/the-arthritispower-wearable-study-101224https://curecurrent.com/trials/a-study-of-the-efficacy-and-safety-of-taci-antibody-fusion-protein-injection-rc18-in-subjects-with-inadequate-response-t-101225https://curecurrent.com/trials/efficacy-of-chinese-herbal-medicine-qing-re-huo-xue-in-patients-with-rheumatoid-arthritis-101226https://curecurrent.com/trials/study-of-the-causal-link-between-rheumatoid-arthritis-and-periodontitis-using-mendelian-randomization-101227https://curecurrent.com/trials/la-function-and-dimensions-as-predictors-of-disease-activity-in-ra-101228https://curecurrent.com/trials/impact-impact-of-antimalarials-on-covid-19-infections-in-rapport-101229https://curecurrent.com/trials/h-pylori-infection-with-disease-activity-in-systemic-lupus-erythematosus-and-rheumatoid-arthritis-101230https://curecurrent.com/trials/a-study-in-pregnant-women-with-chronic-inflammatory-diseases-treated-with-cimzia-certolizumab-pegol-101231https://curecurrent.com/trials/effectiveness-of-probiotics-in-patients-of-mild-to-moderate-rheumatoid-arthritis-101232https://curecurrent.com/trials/study-evaluating-pharmacokinetics-pharmacodynamics-immunogenicity-and-safety-profiles-of-rituximab-compared-to-mabthera-101233https://curecurrent.com/trials/a-clinical-investigation-of-the-vanguard-complete-knee-system-101234https://curecurrent.com/trials/role-of-platelets-in-the-pathophysiology-of-systemic-lupus-101235https://curecurrent.com/trials/study-comparing-doses-of-an-experimental-glucocorticoid-compound-to-prednisone-and-placebo-in-rheumatoid-arthritis-101236https://curecurrent.com/trials/df-oat-bran-intervention-on-inflammation-intestinal-flora-disease-activity-and-quality-of-life-in-patients-with-ra-101237https://curecurrent.com/trials/open-label-single-center-study-to-evaluate-the-safety-and-efficacy-of-combining-rituximab-and-ab-101-in-b-cell-associate-101238https://curecurrent.com/trials/an-clinical-study-of-yts109-cell-injection-in-subjects-with-recurrent-refractory-autoimmune-disease-101239https://curecurrent.com/trials/capability-of-tofacitinib-or-etanercept-to-accelerate-tapering-of-nsaid-and-treat-to-target-guided-de-escalation-of-cort-101240https://curecurrent.com/trials/effect-of-mtx-discontinuation-on-shingrix-response-in-ra-101241https://curecurrent.com/trials/ultrasonographic-evaluation-of-asymptomatic-shoulder-joint-pathologies-in-rheumatoid-arthritis-patients-101242https://curecurrent.com/trials/korean-post-marketing-surveillance-for-xeljanz-101243https://curecurrent.com/trials/effect-of-butyrate-supplement-on-rheumatoid-arthritis-101244https://curecurrent.com/trials/fecal-microbial-transplantation-for-rheumatoid-arthritis-trial-101245https://curecurrent.com/trials/carpal-bone-erosion-in-rheumatoid-arthritis-diagnostic-value-101246https://curecurrent.com/trials/il-6-il-12-il-15-and-il-23-expression-levels-in-rheumatoid-arthritis-patients-101247https://curecurrent.com/trials/study-in-subjects-with-rheumatoid-arthritis-to-evaluate-the-effect-of-a-single-dose-of-olokizumab-on-the-pharmacokinetic-101248https://curecurrent.com/trials/study-evaluating-single-doses-of-sbi-087-in-japanese-subjects-with-rheumatoid-arthritis-101249https://curecurrent.com/trials/standard-versus-high-dose-inactivated-influenza-vaccine-in-ra-101250https://curecurrent.com/trials/journey-ii-xr-safety-and-effectiveness-pmcf-101251https://curecurrent.com/trials/drug-management-of-rheumatoid-arthritis-in-covid-19-context-impact-on-therapeutic-de-escalation-101252https://curecurrent.com/trials/integration-of-remote-monitoring-in-the-management-of-chronic-immunosuppressive-therapy-101253https://curecurrent.com/trials/treat-to-target-in-ra-collaboration-to-improve-adoption-and-adherence-101254https://curecurrent.com/trials/functional-analysis-of-salivary-glands-and-correlation-with-sialoscintigraphy-in-sjogren-s-syndrome-101255https://curecurrent.com/trials/the-relationship-between-serum-chemokine-ligand-21-ccl-21-level-and-disease-activity-101256https://curecurrent.com/trials/the-effect-of-distant-reiki-application-on-pain-functional-status-and-sleep-quality-101257https://curecurrent.com/trials/diagnostic-interest-of-the-buccal-schirmer-test-in-xerostomia-during-sj-gren-s-syndrome-xerodiag-101258https://curecurrent.com/trials/filgotinib-effect-on-proteomic-profile-and-micro-rna-expression-in-patients-with-active-rheumatoid-arthritis-ra-101259https://curecurrent.com/trials/e-learning-in-patient-education-to-patients-with-rheumatoid-arthritis-101260https://curecurrent.com/trials/a-study-to-evaluate-the-effectiveness-and-safety-of-ski-o-703-in-patients-experiencing-active-rheumatoid-arthritis-despi-101261https://curecurrent.com/trials/a-study-to-evaluate-biomarkers-to-predict-efficacy-of-abatacept-in-rheumatoid-arthritis-101262https://curecurrent.com/trials/exceed-abt-acetabular-cup-cementless-system-101263https://curecurrent.com/trials/a-phase-1-clinical-trial-dhp2306r1-and-dhp2306r2-in-healthy-adult-volunteers-101264https://curecurrent.com/trials/textured-insoles-and-foot-massage-in-individuals-diagnosed-with-rheumatoid-arthritis-101265https://curecurrent.com/trials/persona-tm-tibia-clinical-outcomes-study-101266https://curecurrent.com/trials/barriers-and-faciliators-for-physical-activity-in-people-with-rmds-101267https://curecurrent.com/trials/use-of-thermography-for-the-prevention-and-diagnosis-of-rheumatic-foot-101268https://curecurrent.com/trials/emdr-on-pain-in-patients-with-in-patients-rheumatoid-arthritis-101269https://curecurrent.com/trials/golimumab-for-adherence-in-rheumatoid-arthritis-101270https://curecurrent.com/trials/a-phase-3-study-to-compare-upadacitinib-to-abatacept-in-subjects-with-rheumatoid-arthritis-on-stable-dose-of-conventiona-101271https://curecurrent.com/trials/efficacy-and-safety-of-cdp6038-in-patients-with-rheumatoid-arthritis-with-an-unsuccessful-response-to-anti-tumor-necrosi-101272https://curecurrent.com/trials/active-pharmacovigilance-study-of-the-medicine-rinvoq-upadacitinib-101273https://curecurrent.com/trials/clinical-study-of-18f-fapi-rgd-pet-ct-in-rheumatoid-arthritis-101274https://curecurrent.com/trials/sarah-exercise-program-in-patients-with-rheumatoid-arthritis-101275https://curecurrent.com/trials/a-study-of-the-safety-tolerability-and-efficacy-of-treatment-with-ap1189-in-early-ra-patients-with-active-joint-disease-101276https://curecurrent.com/trials/il-7-and-il-7r-expression-in-ra-patients-with-active-vs-inactive-disease-treated-with-dmard-or-cimzia-101277https://curecurrent.com/trials/proactive-therapeutic-drug-monitoring-based-adalimumab-therapy-optimization-in-patients-with-rheumatoid-arthritis-101278https://curecurrent.com/trials/low-dose-interleukin-2-and-rapamycin-on-sj-gren-s-syndrome-101279https://curecurrent.com/trials/impact-of-a-high-fiber-diet-on-the-microbiome-and-disease-activity-in-patients-with-rheumatoid-arthritis-101280https://curecurrent.com/trials/biomarkers-associated-with-temporomandibular-disorders-in-patients-with-rheumatoid-arthritis-101281https://curecurrent.com/trials/comparison-of-complarate-tocilizumab-biosimilar-and-actemra-in-patients-with-rheumatoid-arthritis-101282https://curecurrent.com/trials/rheumatoid-arthritis-memory-b-cells-and-abatacept-101283https://curecurrent.com/trials/assessing-the-efficacy-of-a-carbamide-peroxide-mouthwash-for-oral-wound-healing-oral-hygiene-and-xerostomia-relief-101284https://curecurrent.com/trials/effect-of-exercise-type-on-muscle-quality-in-patients-with-oa-sarc-and-ra-an-explorative-study-101285https://curecurrent.com/trials/exosome-mirna-and-transcriptome-profiling-of-dry-eye-syndrome-and-sjogren-s-syndrome-101286https://curecurrent.com/trials/ultra-high-frequency-ultrasonography-in-sj-gren-s-syndrome-101287https://curecurrent.com/trials/reliability-validity-and-responsiveness-of-the-turkish-version-of-eating-assessment-tool-10-for-patients-with-primer-sj-101288https://curecurrent.com/trials/trauma-informed-intervention-for-rheumatoid-arthritis-on-blackfeet-nation-101289https://curecurrent.com/trials/a-pilot-proof-of-concept-study-of-the-effects-of-administration-of-scfa-in-rheumatoid-arthritis-easi-ra-101290https://curecurrent.com/trials/total-temporomandibular-joint-replacement-system-post-approval-study-101291https://curecurrent.com/trials/a-two-part-12-week-study-of-etoricoxib-as-a-treatment-for-rheumatoid-arthritis-ra-mk-0663-107-101292https://curecurrent.com/trials/effects-of-kaltenborn-versus-mulligan-techniques-in-rheumatoid-arthritis-101293https://curecurrent.com/trials/pulse-steroid-injection-in-refractory-rheumatoid-arthritis-101294https://curecurrent.com/trials/histopathological-analysis-versus-full-field-optical-coherence-tomography-of-minor-salivary-gland-biopsy-in-suspect-sjog-101295https://curecurrent.com/trials/saphir-assessment-of-predictive-factors-for-persistence-of-treatment-after-initiation-of-adalimumab-with-a-biosimilar-ad-101296https://curecurrent.com/trials/prevalence-of-pre-clinical-sj-gren-disease-and-other-immune-disturbances-in-subjects-with-autoimmune-thyroiditis-disease-101297https://curecurrent.com/trials/comparative-effectiveness-of-different-drugs-used-to-tr-at-patients-in-rheumatoid-arthritis-saudi-database-rasd-101298https://curecurrent.com/trials/therapeutic-response-of-cannabidiol-in-rheumatoid-arthritis-101299https://curecurrent.com/trials/physical-activity-and-cardiovascular-risk-101300https://curecurrent.com/trials/long-term-follow-up-study-of-glpg0634-in-active-rheumatoid-arthritis-participants-101301https://curecurrent.com/trials/evaluating-the-effect-of-ursodeoxycholic-acid-in-patients-with-rheumatoid-arthritis-101302https://curecurrent.com/trials/effect-of-endodontic-treatment-on-inflammatory-markers-disease-activity-and-periapical-healing-in-rheumatoid-arthritis-p-101303https://curecurrent.com/trials/effects-of-tofacitinib-vs-methotrexate-on-rheumatoid-arthritis-interstitial-lung-disease-101304https://curecurrent.com/trials/considerate-study-splenic-stimulation-for-ra-101305https://curecurrent.com/trials/clinical-evaluation-of-vanguard-dd-rp-101306https://curecurrent.com/trials/the-safety-and-efficacy-of-anti-cd19-car-t-cells-in-patients-with-relapsed-refractory-autoimmune-diseases-101307https://curecurrent.com/trials/evaluation-of-a-new-screening-method-for-sarcopenia-in-rheumatoid-arthritis-101308https://curecurrent.com/trials/observational-study-of-pediatric-rheumatic-and-immunologic-diseases-in-china-the-caprid-registry-101309https://curecurrent.com/trials/preliminary-clinical-study-of-utaa09-injection-in-the-treatment-of-relapsed-refractory-autoimmune-diseases-101310https://curecurrent.com/trials/belimumab-after-rituximab-in-resistant-primary-juvenile-ss-101311https://curecurrent.com/trials/a-2-year-phase-3-study-of-cp-690-550-in-patients-with-active-rheumatoid-arthritis-on-background-methotrexate-101312https://curecurrent.com/trials/multiple-ascending-doses-of-rozibafusp-alfa-amg-570-in-adults-with-rheumatoid-arthritis-101313https://curecurrent.com/trials/tapering-of-biologics-in-inflammatory-arthritis-patients-in-remission-101314https://curecurrent.com/trials/acupressure-in-rheumatoid-arthritis-101315https://curecurrent.com/trials/rheumatoid-arthritis-adrenal-recovery-study-101316https://curecurrent.com/trials/muscle-wasting-and-rheumatoid-arthritis-flares-101317https://curecurrent.com/trials/drug-compliance-and-affecting-factors-in-juvenile-idiopathic-arthritis-101318https://curecurrent.com/trials/defining-the-molecular-and-radiologic-phenotype-of-progressive-ra-interstitial-lung-disease-101319https://curecurrent.com/trials/adversity-and-its-association-with-the-development-and-expression-of-rheumatic-diseases-101320https://curecurrent.com/trials/rosa-robot-used-in-total-knee-replacement-post-market-study-101321https://curecurrent.com/trials/effectiveness-of-digital-rehabilitation-simpli-rehab-in-hand-arthritis-101322https://curecurrent.com/trials/study-to-evaluate-the-effect-of-filgotinib-on-semen-parameters-in-adult-males-with-active-rheumatoid-arthritis-psoriatic-101323https://curecurrent.com/trials/predict-therapy-selection-for-jak-t-cell-or-il-6-inhibitor-therapies-using-a-molecular-signature-response-classifier-pre-101324https://curecurrent.com/trials/korean-college-of-rheumatology-biologics-and-targeted-therapy-registry-101325https://curecurrent.com/trials/a-study-on-the-prevention-and-treatment-of-giop-with-eldecalcitol-101326https://curecurrent.com/trials/follow-up-of-person-centered-care-of-young-adults-with-rheumatic-disease-101327https://curecurrent.com/trials/efficacy-and-safety-of-s95011-in-primary-sj-gren-s-syndrome-patients-101328https://curecurrent.com/trials/proximod-pharmacokinetics-in-healthy-subjects-and-patients-with-rheumatoid-arthritis-101329https://curecurrent.com/trials/chronic-periodontitis-and-tooth-loss-in-patients-with-rheumatoid-arthritis-101330https://curecurrent.com/trials/adalimumab-drug-optimisation-in-rheumatoid-arthritis-using-therapeutic-drug-monitoring-101331https://curecurrent.com/trials/anti-cd19-cd3e-car-t-cells-in-relapsed-refractory-autoimmune-disease-101332https://curecurrent.com/trials/use-of-tocilizumab-drug-levels-to-optimize-treatment-in-ra-101333https://curecurrent.com/trials/ultrasound-efficacy-in-moderate-rheumatoid-arthritis-101334https://curecurrent.com/trials/cequa-for-sjogren-s-syndrome-dry-eye-101335https://curecurrent.com/trials/this-is-a-retrospective-observational-study-looking-at-the-characteristics-and-outcomes-of-participants-taking-inflectra-101336https://curecurrent.com/trials/comparative-effectiveness-of-tumor-necrosis-factor-inhibitors-and-tofacitinib-use-in-earlier-lines-of-therapy-and-use-as-101337https://curecurrent.com/trials/proximod-pharmacokinetics-in-healthy-subjects-101338https://curecurrent.com/trials/compare-diagnostic-performance-of-dixon-chess-sequences-calculating-ramris-score-in-early-rheumatoid-arthritis-101339https://curecurrent.com/trials/cervical-stabilization-exercises-in-patients-with-rheumatoid-arthritis-101340https://curecurrent.com/trials/vanguard-rocc-post-market-surveillance-101341https://curecurrent.com/trials/cilostazol-and-methotrexate-in-rheumatoid-arthritis-101342https://curecurrent.com/trials/detection-of-pathological-lymphocytes-in-patients-with-autoimmune-disease-101343https://curecurrent.com/trials/comparative-analysis-of-adherence-and-effectiveness-outcomes-between-rheumatoid-arthritis-ra-patients-treated-with-tofac-101344https://curecurrent.com/trials/rheumatoid-arthritis-planned-behav-or-theory-and-nurse-counsel-ng-101345https://curecurrent.com/trials/effects-of-case-management-for-patients-with-rheumatoid-arthritis-in-taiwan-101346https://curecurrent.com/trials/effects-of-virtual-reality-on-brain-hemodynamic-activity-in-chronic-pain-101347https://curecurrent.com/trials/efficacy-and-safety-of-gsk3196165-versus-placebo-and-tofacitinib-in-participants-with-moderately-to-severely-active-rheu-101348https://curecurrent.com/trials/covid-19-coronavac-in-patients-with-autoimmune-rheumatic-diseases-and-hiv-aids-101349https://curecurrent.com/trials/efficacy-study-of-iguratimod-combined-with-tofacitab-in-patients-with-rf-positive-negative-rheumatoid-arthritis-101350https://curecurrent.com/trials/safety-tolerability-pharmacokinetics-pharmacodynamics-and-clinical-effects-of-multiple-rising-subcutaneous-doses-of-bi-6-101351https://curecurrent.com/trials/post-market-clinical-follow-up-study-for-evolution-biofoam-tibia-and-evolution-cs-cr-porous-femur-101352https://curecurrent.com/trials/post-market-clinical-follow-up-study-evolution-revision-cck-101353https://curecurrent.com/trials/study-of-the-impact-of-fatty-acids-from-seal-oil-on-the-relief-of-symptoms-associated-with-rheumatoid-arthritis-101354https://curecurrent.com/trials/feasibility-study-plant-based-diet-to-patients-with-rheumatoid-arthritis-101355https://curecurrent.com/trials/evadry-in-the-treatment-of-xerostomia-in-sj-gren-s-syndrome-101356https://curecurrent.com/trials/clinical-study-on-the-deep-remission-of-rheumatoid-arthritis-with-kidney-deficiency-and-excessive-cold-syndrome-by-bushe-101357https://curecurrent.com/trials/a-study-to-assess-the-efficacy-and-safety-of-burfiralimab-hzvsf-v13-and-dmrd-disease-modifying-antirheumatic-drug-101358https://curecurrent.com/trials/a-clinical-utility-study-of-prismra-for-rheumatoid-arthritis-101359https://curecurrent.com/trials/examining-the-efficacy-of-personalized-lifestyle-intervention-in-individuals-with-rheumatoid-arthritis-101360https://curecurrent.com/trials/a-clinical-study-with-adalimumab-biosimilar-101361https://curecurrent.com/trials/a-phase-2-study-of-hemay007-in-patients-with-rheumatoid-arthritis-101362https://curecurrent.com/trials/monitoring-of-inflammatory-conditions-101363https://curecurrent.com/trials/presence-and-comparison-of-sarcopenia-in-early-rheumatoid-arthritis-and-rheumatoid-arthritis-101364https://curecurrent.com/trials/motec-versus-remotion-total-wrist-arthroplasty-a-prospective-study-101365https://curecurrent.com/trials/fish-oil-omega-3-in-sjogren-s-syndrome-101366https://curecurrent.com/trials/stopping-tnf-alpha-inhibitors-in-rheumatoid-arthritis-101367https://curecurrent.com/trials/hydroxychloroquine-blood-levels-in-primary-sj-gren-syndrome-patients-101368https://curecurrent.com/trials/effect-of-silymarin-against-methotrexate-induced-liver-injury-in-rheumatic-diseases-101369https://curecurrent.com/trials/vaccine-response-to-covid-19-vaccines-in-patients-using-immunosuppressive-medication-101370https://curecurrent.com/trials/towards-telemonitoring-in-immune-mediated-inflammatory-diseases-implementation-of-a-mixed-attention-model-imidoc-101371https://curecurrent.com/trials/a-comparative-study-between-pf-06410293-and-humira-in-combination-with-methotrexate-in-participants-with-active-rheumato-101372https://curecurrent.com/trials/the-relationship-between-rheumatoid-arthritis-and-osteoporosis-and-factors-contributing-to-this-connection-101373https://curecurrent.com/trials/tivanisiran-for-dry-eye-in-subjects-with-sj-gren-s-syndrome-101374https://curecurrent.com/trials/a-tailored-psychological-intervention-mitig-ra-for-managing-fatigue-in-rheumatoid-arthritis-101375https://curecurrent.com/trials/safety-of-splenic-stimulation-for-ra-101376https://curecurrent.com/trials/montelukast-use-in-rheumatoid-arthritis-101377https://curecurrent.com/trials/a-study-to-assess-the-pharmacokinetics-of-certolizumab-pegol-in-adults-with-active-rheumatoid-arthritis-101378https://curecurrent.com/trials/long-term-safety-and-efficacy-of-gsk3196165-otilimab-in-the-treatment-of-rheumatoid-arthritis-ra-101379https://curecurrent.com/trials/bone-microarchitectural-database-constitution-from-hr-pqct-device-in-clinical-situation-potentially-associated-with-bone-101380https://curecurrent.com/trials/dual-polymer-hydroxypropyl-guar-and-hyaluronic-acid-lubricants-in-rheumatoid-arthritis-101381https://curecurrent.com/trials/neutrophil-lymphocyte-ratio-and-platelet-lymphocyte-ratio-in-rheumatoid-arthritis-101382https://curecurrent.com/trials/trivalent-chromium-treatment-for-rheumatoid-arthritis-101383https://curecurrent.com/trials/people-powered-medicine-ppm-rheumatoid-arthritis-non-responders-to-biologic-therapies-rant-101384https://curecurrent.com/trials/exercise-induced-cardiac-adaptions-in-rheumatoid-arthritis-patients-during-il-6-vs-tnf-antibody-therapy-101385https://curecurrent.com/trials/the-effects-of-acthar-on-synovial-inflammation-in-rheumatoid-arthritis-101386https://curecurrent.com/trials/rheumatoid-arthritis-and-myositis-cohort-101387https://curecurrent.com/trials/opam-ia-using-digital-activity-trackers-to-improve-physical-activity-in-inflammatory-arthritis-101388https://curecurrent.com/trials/a-study-comparing-upadacitinib-abt-494-monotherapy-to-methotrexate-mtx-monotherapy-in-adults-with-rheumatoid-arthritis-r-101389https://curecurrent.com/trials/renal-resistive-index-as-a-predictor-of-renal-involvement-in-rheumatoid-arthritis-101390https://curecurrent.com/trials/vgh-desjs-1-in-ocular-and-oral-dryness-symptoms-of-dry-eye-syndrome-and-sj-gren-s-syndrome-101391https://curecurrent.com/trials/ankle-joint-replacement-outcomes-study-101392https://curecurrent.com/trials/effect-of-quadriceps-muscle-on-physical-outcome-measures-in-women-with-rheumatoid-arthritis-101393https://curecurrent.com/trials/a-clinical-trial-of-safety-and-tolerance-of-tqh3821-tablets-in-adult-healthy-subjects-101394https://curecurrent.com/trials/comparison-of-training-load-with-out-blood-flow-restriction-training-in-rheumatoid-populations-101395https://curecurrent.com/trials/a-study-to-investigate-the-ability-of-gsk706769-to-maintain-clinical-remission-after-withdrawal-of-enbrel-in-rheumatoid-101396https://curecurrent.com/trials/an-exploratory-clinical-study-on-bortezomib-for-the-treatment-of-refractory-rheumatoid-arthritis-101397https://curecurrent.com/trials/rheupp-a-rheumatological-follow-up-management-app-101398https://curecurrent.com/trials/genetic-and-social-network-correlates-of-rheumatoid-arthritis-outcomes-in-hispanic-populations-a-prospective-study-101399https://curecurrent.com/trials/smart-marker-annunciating-response-to-rheumatologic-treatments-smart-t-101400https://curecurrent.com/trials/study-of-the-functional-status-neutrophils-in-rheumatoid-arthritis-patients-to-identify-new-biomarkers-of-response-to-an-101401https://curecurrent.com/trials/study-to-assess-safety-and-effectiveness-of-branebrutinib-treatment-in-participants-with-active-systemic-lupus-erythemat-101402https://curecurrent.com/trials/identification-of-new-biomarkers-to-promote-personalized-treatment-of-patients-with-inflammatory-rheumatic-diseases-101403https://curecurrent.com/trials/post-market-clinical-follow-up-study-protocol-for-profemur-gladiator-ha-coated-modular-femoral-stems-101404https://curecurrent.com/trials/assessment-of-safety-tolerability-pharmacokinetics-and-pharmacodynamics-of-apb-r3-101405https://curecurrent.com/trials/study-of-wrist-fusions-with-the-medartis-aptus-arthrodesis-plate-101406https://curecurrent.com/trials/metacarpophalangeal-joint-prostheses-in-hand-surgery-101407https://curecurrent.com/trials/comparative-study-of-3-tocilizumab-products-in-normal-healthy-volunteeers-101408https://curecurrent.com/trials/an-exploratory-clinical-study-on-autophagy-during-fasting-101409https://curecurrent.com/trials/medical-trial-appraising-medical-trial-experiences-of-rheumatoid-arthritis-patients-101410https://curecurrent.com/trials/rheumatoid-arthritis-associated-interstitial-lung-disease-definition-101411https://curecurrent.com/trials/arthroscopic-synovectomy-of-the-wrist-in-inflammatory-arthritis-101412https://curecurrent.com/trials/clinical-evaluation-of-the-titan-total-shoulder-system-101413https://curecurrent.com/trials/understanding-ayurveda-disease-conditions-and-treatment-responses-101414https://curecurrent.com/trials/predicting-the-response-of-patients-with-rheumatoid-arthritis-to-treatment-with-genetically-engineered-biological-drugs-101415https://curecurrent.com/trials/improving-beliefs-about-medication-in-patients-with-rheumatoid-arthritis-101416https://curecurrent.com/trials/study-comparing-etanercept-plus-methotrexate-to-either-etanercept-or-methotrexate-alone-in-rheumatoid-arthritis-101417https://curecurrent.com/trials/pragmatic-study-comparing-the-clinical-evlauation-methods-c-and-or-ultrasound-method-b-or-d-in-rheumatoid-arthritis-to-a-101418https://curecurrent.com/trials/an-extension-study-of-wa19926-of-the-long-term-safety-of-tocilizumab-roactemra-actemra-in-patients-with-early-moderate-t-101419https://curecurrent.com/trials/study-of-the-tolerability-of-different-sar153191-drug-products-that-differ-with-respect-to-manufacturing-processes-and-f-101420https://curecurrent.com/trials/central-aspects-of-pain-in-rheumatoid-arthritis-101421https://curecurrent.com/trials/safety-and-efficacy-of-abatacept-for-treating-chronic-cytopenia-in-cytotoxic-t-lymphocyte-antigen-4-ctla4-haploinsuffici-101422https://curecurrent.com/trials/autologous-tolerogenic-dendritic-cells-for-rheumatoid-arthritis-autodecra-101423https://curecurrent.com/trials/efficacy-and-safety-of-gsk3196165-versus-placebo-and-tofacitinib-in-participants-with-moderately-to-severely-active-rheu-101424https://curecurrent.com/trials/an-efficacy-and-safety-study-of-subcutaneous-tocilizumab-in-combination-with-methotrexate-mtx-and-as-monotherapy-versus-101425https://curecurrent.com/trials/alendronate-treatment-of-osteoporosis-in-rheumatoid-arthritis-101426https://curecurrent.com/trials/educar-improving-adherence-in-rheumatoid-arthritis-101427https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-and-safety-of-shr0302-in-patients-with-rheumatoid-arthritis-101428https://curecurrent.com/trials/home-monitoring-of-patients-with-chronic-diseases-an-erehab-test-retest-study-101429https://curecurrent.com/trials/a-study-of-pf-04171327-in-the-treatment-of-the-signs-and-symptoms-of-rheumatoid-arthritis-101430https://curecurrent.com/trials/temporomandibular-joint-in-patients-with-rheumatoid-arthritis-101431https://curecurrent.com/trials/the-cartilage-and-muscle-thickness-on-knee-pain-in-patients-with-rheumatoid-arthritis-101432https://curecurrent.com/trials/adalimumab-dose-reduction-aiming-low-serum-concentration-with-control-of-disease-activity-101433https://curecurrent.com/trials/sonoelastography-of-median-nerve-in-rheumatoid-arthritis-101434https://curecurrent.com/trials/using-adalimumab-serum-concentration-to-choose-a-subsequent-biological-dmard-in-rheumatoid-arthritis-patients-failing-ad-101435https://curecurrent.com/trials/the-efficacy-and-safety-of-tacrolimus-in-refractory-rheumatoid-arthritis-patients-for-6-months-and-long-term-treatment-101436https://curecurrent.com/trials/immunosuppressant-combined-with-pirfenidone-in-ctd-ild-101437https://curecurrent.com/trials/a-phase-iii-transition-study-of-drl-rituximab-to-reference-medicinal-products-101438https://curecurrent.com/trials/baricitinib-cognitive-emotional-and-neural-signature-101439https://curecurrent.com/trials/efficacy-and-safety-of-baricitinib-for-the-treatment-of-moderate-to-severe-rheumatoid-arthritis-101440https://curecurrent.com/trials/the-clinical-efficacy-and-safety-of-iguratimod-in-ra-and-early-ra-patients-for-6-months-treatment-101441https://curecurrent.com/trials/post-market-clinical-follow-up-study-protocol-for-profemur-tl-modular-femoral-stems-101442https://curecurrent.com/trials/the-efficacy-and-safety-of-tofacitinib-tf-with-iguratimod-igu-on-ra-101443https://curecurrent.com/trials/serum-il-17-correlated-with-inflammatory-changes-in-osteoarthritis-and-rheumatoid-arthritis-101444https://curecurrent.com/trials/post-market-clinical-follow-up-study-protocol-for-procotyl-c-acetabular-components-101445https://curecurrent.com/trials/comparative-pharmacokinetic-study-of-three-abatacept-products-in-male-normal-healthy-volunteers-by-the-subcutaneous-rout-101446https://curecurrent.com/trials/acupuncture-study-on-rheumatoid-arthritis-monitoring-microbiome-and-blood-101447https://curecurrent.com/trials/clinical-evaluation-of-the-integra-titan-modular-shoulder-system-generation-2-5-for-primary-shoulder-joint-replacement-101448https://curecurrent.com/trials/a-safety-efficacy-study-of-treatment-with-ap1189-in-rheumatoid-arthritis-patients-na-ve-to-dmard-treatment-101449https://curecurrent.com/trials/assessment-of-anxiety-depression-sleep-quality-and-quality-of-life-in-rheumatoid-arthritis-patients-101450https://curecurrent.com/trials/a-phase-i-clinical-study-of-vc005-tablets-in-subjects-with-rheumatoid-arthritis-101451https://curecurrent.com/trials/periodontal-disease-and-p-gingivalis-in-rheumatoid-arthritis-101452https://curecurrent.com/trials/value-of-kl-6-in-rheumatoid-arthritis-associated-ild-101453https://curecurrent.com/trials/probing-the-rheumatoid-arthritis-brain-to-elucidate-central-pain-pathways-101454https://curecurrent.com/trials/exploiting-leading-edge-7t-mri-brain-imaging-to-decipher-olumiant-s-mode-of-analgesic-action-in-rheumatoid-arthritis-101455https://curecurrent.com/trials/safety-and-tolerability-study-of-pf-06835375-in-subjects-with-seropositive-systemic-lupus-erythematosus-or-rheumatoid-ar-101456https://curecurrent.com/trials/methotrexate-use-improvement-in-rheumatoid-arthritis-using-biomarker-feedback-101457https://curecurrent.com/trials/pilot-study-to-investigate-the-feasibility-reliability-and-efficacy-of-utilizing-oct-to-automate-prose-fitting-101458https://curecurrent.com/trials/a-study-of-lnk01001-capsule-in-moderately-to-severely-active-rheumatoid-arthritis-101459https://curecurrent.com/trials/prevalence-of-subclinical-vertebral-fractures-in-rheumatoid-arthritis-and-ankylosing-spondylitis-101460https://curecurrent.com/trials/zimmer-polar-total-knee-arthroplasty-tka-101461https://curecurrent.com/trials/ultrasound-treatment-for-rheumatoid-arthritis-study-ultra-study-101462https://curecurrent.com/trials/efficacy-and-safety-of-olokizumab-in-subjects-with-moderately-to-severely-active-rheumatoid-arthritis-101463https://curecurrent.com/trials/chronic-pain-couples-physical-activity-101464https://curecurrent.com/trials/ascension-post-approval-study-pyrocarbon-metacarpophalangeal-total-joint-prosthesis-101465https://curecurrent.com/trials/treatment-of-early-ra-minocycline-in-combination-with-methotrexate-vs-methotrexate-alone-101466https://curecurrent.com/trials/the-reliability-and-validity-of-a-smartphone-app-101467https://curecurrent.com/trials/distress-in-rheumatoid-arthritis-patients-101468https://curecurrent.com/trials/breaking-up-sedentary-time-in-rheumatoid-arthritis-101469https://curecurrent.com/trials/triple-iii-comparison-of-leflunomide-alone-versus-two-dmard-combinations-in-the-treatment-of-rheumatoid-arthritis-101470https://curecurrent.com/trials/a-study-to-investigate-and-describe-the-treatment-patterns-and-effect-of-tofacitinib-indicators-for-patients-with-rheuma-101471https://curecurrent.com/trials/curcumin-in-rheumatoid-arthritis-101472https://curecurrent.com/trials/safety-and-efficacy-of-cd19-targeted-car-t-therapy-for-refractory-autoimmune-disease-101473https://curecurrent.com/trials/cohort-project-of-patients-with-inflammatory-rheumatism-101474https://curecurrent.com/trials/mobile-medically-supervised-patient-management-in-rheumatoid-arthritis-101475https://curecurrent.com/trials/cormet-large-diameter-metal-on-metal-ldmom-total-hip-system-g030265-101476https://curecurrent.com/trials/phase-iii-clinical-trial-comparing-the-safety-efficacy-and-immunogenicity-of-recombinant-anti-interleukin-6-receptor-hum-101477https://curecurrent.com/trials/rebamipide-regular-nanoparticulated-vs-clobetasol-in-management-of-methotrexate-induced-oral-ulceration-in-rheumatoid-ar-101478https://curecurrent.com/trials/evaluation-of-the-efficacy-and-safety-of-two-dosing-regimens-of-olokizumab-okz-compared-to-placebo-in-subjects-with-rheu-101479https://curecurrent.com/trials/evaluation-of-the-effectiveness-and-safety-of-two-dosing-regimens-of-olokizumab-okz-compared-to-placebo-in-subjects-with-101480https://curecurrent.com/trials/99mtc-3prgd2-spect-ct-in-rheumatoid-arthritis-patients-101481https://curecurrent.com/trials/evaluation-of-the-efficacy-and-safety-of-two-dosing-regimens-of-olokizumab-okz-compared-to-placebo-and-adalimumab-in-sub-101482https://curecurrent.com/trials/oral-cf101-and-methotrexate-treatment-in-rheumatoid-arthritis-patients-101483https://curecurrent.com/trials/a-study-evaluating-the-effects-of-glpg3970-given-as-an-oral-treatment-for-12-weeks-in-adults-with-active-primary-sj-gren-101484https://curecurrent.com/trials/anterior-advantage-with-kincise-101485https://curecurrent.com/trials/investigation-on-risk-factors-of-rheumatoid-arthritis-related-interstitial-lung-disease-101486https://curecurrent.com/trials/microbiota-analysis-to-predict-outcomes-of-rheumatoid-arthritis-patients-treated-with-jak-inhibitor-101487https://curecurrent.com/trials/gut-microbiota-a-player-in-chronic-pain-in-patients-with-rheumatoid-arthritis-101488https://curecurrent.com/trials/study-evaluating-single-doses-of-sbi-087-in-subjects-with-rheumatoid-arthritis-101489https://curecurrent.com/trials/abatacept-vs-tocilizumab-for-the-treatment-of-ra-in-tnf-alpha-inhibitor-inadequate-responders-101490https://curecurrent.com/trials/clinical-risk-assessment-of-cognitive-function-in-systemic-autoimmune-diseases-101491https://curecurrent.com/trials/effect-of-controlling-environmental-risk-factors-in-established-ra-101492https://curecurrent.com/trials/evaluation-of-a-connected-interface-to-improve-the-quality-of-life-and-the-disability-of-patient-with-rheumatic-diseases-101493https://curecurrent.com/trials/early-ra-mri-early-intensive-treatment-study-101494https://curecurrent.com/trials/eccentric-versus-concentric-exercises-for-rotator-cuff-tendinopathy-in-patients-with-rheumatoid-arthritis-101495https://curecurrent.com/trials/early-ra-vascular-randomised-controlled-study-101496https://curecurrent.com/trials/enthesis-differences-in-rheumatoid-arthritis-and-axial-spondyloarthropathy-101497https://curecurrent.com/trials/effects-of-achieving-sdai-remission-on-joint-space-outcomes-progression-in-early-rheumatoid-arthritis-an-hr-pqct-study-101498https://curecurrent.com/trials/acth-gel-therapy-in-rheumatoid-arthritis-101499https://curecurrent.com/trials/the-safety-and-efficacy-of-tll-018-in-active-rheumatoid-arthritis-101500https://curecurrent.com/trials/rheumatoid-arthritis-comorbidity-bone-health-in-men-and-african-americans-101501https://curecurrent.com/trials/corin-minihip-and-trinity-cup-clinical-surveillance-study-101502https://curecurrent.com/trials/gene-environment-interactions-in-rheumatoid-arthritis-autoimmunity-disease-severity-101503https://curecurrent.com/trials/the-survey-of-satisfaction-in-chinese-rheumatologists-and-patients-with-rheumatoid-arthritis-101504https://curecurrent.com/trials/the-effect-of-a-plant-based-diet-on-the-active-rheumatoid-arthritis-activity-101505https://curecurrent.com/trials/bortezomib-for-the-treatment-of-refractory-rheumatoid-arthritis-101506https://curecurrent.com/trials/effect-of-exercise-on-the-disease-activity-of-rheumatoid-arthritis-101507https://curecurrent.com/trials/ast-combined-with-0-05-cyclosporin-eye-drop-improve-corneal-nerve-density-in-patients-with-ss-dry-eye-101508https://curecurrent.com/trials/carpal-tunnel-syndrome-evaluation-with-ultrasound-in-rheumatoid-arthritis-patients-101509https://curecurrent.com/trials/evaluation-of-the-precision-and-sensitivity-of-tilmanocept-uptake-value-tuv-on-tc-99m-tilmanocept-planar-imaging-101510https://curecurrent.com/trials/a-study-to-evaluate-camoteskimab-in-participants-with-still-s-disease-101511https://curecurrent.com/trials/fatigue-in-patients-with-rheumatoid-arthritis-101512https://curecurrent.com/trials/the-effect-of-mixture-of-natural-products-as-salivary-substitutes-in-treatment-of-xerostomia-101513https://curecurrent.com/trials/impact-of-guided-care-with-the-vectra-multi-biomarker-disease-activity-mbda-blood-test-101514https://curecurrent.com/trials/neuropathic-pain-symptoms-in-arthritis-101515https://curecurrent.com/trials/mabioncd20-compared-to-mabthera-and-rituxan-in-patients-with-rheumatoid-arthritis-101516https://curecurrent.com/trials/lifestyle-intervention-for-rheumatoid-arthritis-101517https://curecurrent.com/trials/the-research-registry-for-neonatal-lupus-101518https://curecurrent.com/trials/role-of-topical-vancomycin-in-reducing-infections-in-hip-and-knee-arthroplasty-101519https://curecurrent.com/trials/the-effects-of-jing-si-herbal-tea-liquid-packets-on-fatigue-in-patients-with-inflammatory-arthritis-101520https://curecurrent.com/trials/incidence-of-hospitalizations-for-serious-infections-in-patients-receiving-biologic-anti-inflammatories-for-rheumatologi-101521https://curecurrent.com/trials/comorbidities-and-outcomes-in-early-rheumatoid-arthritis-101522https://curecurrent.com/trials/fetal-hope-study-home-monitoring-of-fetal-heart-rate-in-ssa-pregnant-women-101523https://curecurrent.com/trials/dissecting-the-cellular-and-molecular-atlas-of-rheumatoid-arthritis-in-sustained-remission-to-identify-pathways-maintain-101524https://curecurrent.com/trials/aonda-therapeutic-indication-study-i-101525https://curecurrent.com/trials/abatacept-pregnancy-exposure-registry-101526https://curecurrent.com/trials/the-effect-of-chewing-gum-exercises-of-the-tongue-lip-jaw-on-salivation-xerostomia-dysphagia-in-sj-gren-s-syndrome-101527https://curecurrent.com/trials/a-study-of-the-real-world-use-of-an-adalimumab-biosimilar-and-evaluation-of-nutritional-status-on-the-therapeutic-respon-101528https://curecurrent.com/trials/anti-inflammatory-dietary-intervention-for-rheumatoid-arthritis-101529https://curecurrent.com/trials/the-glucocorticoid-low-dose-outcome-in-rheumatoid-arthritis-study-101530https://curecurrent.com/trials/efficacy-and-safety-of-gsk3196165-otilimab-versus-placebo-and-sarilumab-in-participants-with-moderately-to-severely-acti-101531https://curecurrent.com/trials/omega-3-and-exercise-in-rheumatoid-arthritis-people-101532https://curecurrent.com/trials/musculra-the-effects-of-rheumatoid-arthritis-on-skeletal-muscle-biomechanics-101533https://curecurrent.com/trials/a-study-of-ly3462817-in-participants-with-rheumatoid-arthritis-101534https://curecurrent.com/trials/treatment-of-rheumatoid-hand-with-magnetotherapy-101535https://curecurrent.com/trials/cardiac-and-pulmonary-assessment-in-egyptian-patients-with-rheumatoid-arthritis-101536https://curecurrent.com/trials/myocardial-inflammation-in-rheumatoid-arthritis-a-descriptive-study-101537https://curecurrent.com/trials/this-study-is-to-investigate-the-effect-of-etanercept-in-early-versus-delayed-referral-for-management-of-rheumatoid-arth-101538https://curecurrent.com/trials/truetear-in-sjogren-s-disease-patients-101539https://curecurrent.com/trials/relationship-between-rheumatoid-arthritis-severity-and-cognition-in-the-elderly-the-role-of-nociplastic-pain-101540https://curecurrent.com/trials/a-study-to-compare-upadacitinib-abt-494-monotherapy-to-methotrexate-mtx-monotherapy-in-adults-with-rheumatoid-arthritis-101541https://curecurrent.com/trials/effectiveness-of-therapeutic-exercise-on-the-gut-microbiome-in-chronic-widespread-pain-patients-101542https://curecurrent.com/trials/cystatin-d-fibrinogen-like-protein-1-101543https://curecurrent.com/trials/impact-andhealth-autoimmune-research-registry-101544https://curecurrent.com/trials/the-effects-of-mesenchymal-stem-cell-secretome-in-rheumatoid-arthritis-patients-101545https://curecurrent.com/trials/rheumatoid-arthritis-associated-interstitial-lung-disease-characterization-of-lung-disease-progression-101546https://curecurrent.com/trials/msb11456-in-participants-with-moderately-to-severely-active-rheumatoid-arthritis-101547https://curecurrent.com/trials/superb-microvascular-imaging-ultrasonography-of-lacrimal-gland-in-patients-with-sj-gren-syndrome-101548https://curecurrent.com/trials/all-polyethylene-tibia-vega-kiel-101549https://curecurrent.com/trials/mesenchymal-stem-cells-in-early-rheumatoid-arthritis-101550https://curecurrent.com/trials/exercise-on-microrna-in-rheumatoid-arthritis-101551https://curecurrent.com/trials/subunit-vaccine-against-herpes-zoster-in-ra-patients-treated-with-jak-inhibitors-vaccimil-zoster-101552https://curecurrent.com/trials/a-multi-center-clinical-trial-to-determine-the-impact-of-a-mobile-health-application-on-rheumatoid-arthritis-shared-deci-101553https://curecurrent.com/trials/effects-of-social-networking-on-chronic-disease-management-in-arthritis-101554https://curecurrent.com/trials/a-study-to-investigate-the-effectiveness-of-an-education-support-program-on-medication-adherence-in-italian-real-life-rh-101555https://curecurrent.com/trials/using-thoracic-ultrasound-to-detect-interstitial-lung-disease-in-patients-with-rheumatoid-arthritis-101556https://curecurrent.com/trials/yoga-for-rheumatoid-arthritis-101557https://curecurrent.com/trials/expanded-access-protocol-for-tabelecleucel-for-patients-with-epstein-barr-virus-associated-viremia-or-malignancies-101558https://curecurrent.com/trials/juvenile-inflammatory-rheumatism-jir-cohorte-101559https://curecurrent.com/trials/a-randomized-placebo-controlled-phase-ii-clinical-trial-to-evaluate-the-safety-and-efficacy-of-f8il10-dekavil-in-patient-101560https://curecurrent.com/trials/comparative-analysis-of-outcomes-among-patients-initiating-xeljanz-in-combination-with-oral-mtx-who-withdraw-mtx-versus-101561https://curecurrent.com/trials/a-study-to-evaluate-patient-characteristics-and-treatment-patterns-among-rheumatoid-arthritis-patients-101562https://curecurrent.com/trials/post-market-clinical-follow-up-study-protocol-for-conserve-press-fit-femoral-components-101563https://curecurrent.com/trials/a-causal-relationship-study-between-anxiety-depression-and-rheumatoid-arthritis-101564https://curecurrent.com/trials/post-market-clinical-follow-up-study-protocol-for-dynasty-biofoam-acetabular-components-101565https://curecurrent.com/trials/a-study-to-compare-upadacitinib-abt-494-to-placebo-in-adults-with-rheumatoid-arthritis-ra-who-are-on-a-stable-dose-of-co-101566https://curecurrent.com/trials/application-of-warm-water-and-warm-salt-water-to-patients-with-rheumatoid-arthritis-101567https://curecurrent.com/trials/humor-therapy-and-rheumatoid-arthritis-101568https://curecurrent.com/trials/modified-zhiwang-decoction-combined-with-methotrexate-in-the-treatment-of-early-rheumatoid-arthritis-101569https://curecurrent.com/trials/the-effects-of-low-intensity-training-with-blood-flow-restriction-in-rheumatoid-arthritis-patients-101570https://curecurrent.com/trials/a-study-to-compare-the-effectiveness-of-tofacitinib-11-mg-once-a-day-to-tofacitinib-5-mg-twice-a-day-101571https://curecurrent.com/trials/predicting-medication-response-for-autoimmune-disease-101572https://curecurrent.com/trials/biologics-for-rheumatoid-arthritis-pain-biora-pain-101573https://curecurrent.com/trials/the-effect-of-nursing-follow-up-by-phone-on-the-self-efficacy-pain-disease-activity-in-rheumatoid-arthritis-patients-101574https://curecurrent.com/trials/effectiveness-of-multigrain-supplementation-among-the-rheumatoid-arthritis-patients-101575https://curecurrent.com/trials/an-observational-prospective-study-to-assess-the-efficacy-and-safety-of-adalloce-in-patients-with-ra-and-as-101576https://curecurrent.com/trials/effects-of-abatacept-on-myocarditis-in-rheumatoid-arthritis-101577https://curecurrent.com/trials/evaluation-of-pain-sensitization-in-rheumatoid-arthritis-analysis-on-a-cohort-of-tofacitinib-treated-patients-101578https://curecurrent.com/trials/randomized-fixed-bearing-vs-mobile-bearing-cruciate-substituting-tka-101579https://curecurrent.com/trials/deciphering-rheumatoid-arthritis-associated-interstitial-lung-disease-pathogenesis-2-101580https://curecurrent.com/trials/trial-with-humax-cd4-in-participants-with-rheumatoid-arthritis-ra-failing-treatment-with-methotrexate-mtx-and-a-tnf-alph-101581https://curecurrent.com/trials/tofacitinib-in-the-treatment-of-rheumatoid-arthritis-related-interstitial-lung-disease-101582https://curecurrent.com/trials/role-of-nitazoxanide-and-escitalopram-in-patients-with-rheumatoid-arthritis-101583https://curecurrent.com/trials/alterations-in-cd8-and-cd8-t-cell-levels-in-patients-with-rheumatoid-arthritis-101584https://curecurrent.com/trials/baricitinib-methotrexate-as-monotherapy-or-combination-in-the-treatment-of-rheumatoid-arthritis-an-open-label-randomized-101585https://curecurrent.com/trials/a-real-world-study-of-imraldi-use-101586https://curecurrent.com/trials/autologous-adipose-derived-stem-cells-admscs-for-rheumatoid-arthritis-101587https://curecurrent.com/trials/hepatic-steatosis-and-fibrosis-in-rheumatoid-arthritis-patients-101588https://curecurrent.com/trials/study-to-assess-the-safety-and-efficacy-of-enbrel-administered-by-sofusa-doseconnect-for-rheumatoid-arthritis-101589https://curecurrent.com/trials/a-study-comparing-upadacitinib-abt-494-to-placebo-in-adults-with-rheumatoid-arthritis-on-a-stable-dose-of-conventional-s-101590https://curecurrent.com/trials/to-assess-the-efficacy-and-safety-of-pf-06650833-pf-06651600-and-tofacitinib-alone-and-in-combination-in-participants-wi-101591https://curecurrent.com/trials/post-market-surveillance-study-with-the-hyperion-hip-endoprosthesis-system-in-defect-reconstruction-101592https://curecurrent.com/trials/iguratimod-combined-with-tofacitinib-in-the-treatment-of-rheumatoid-arthritis-101593https://curecurrent.com/trials/information-and-acceptability-of-biosimilars-101594https://curecurrent.com/trials/a-two-stage-study-of-the-efficacy-safety-pharmacokinetics-pharmacodynamics-and-immunogenicity-of-various-doses-of-levili-101595https://curecurrent.com/trials/l-carnitine-in-modulating-pain-and-inflammation-in-rheumatoid-arthritis-101596https://curecurrent.com/trials/the-ra-protection-study-101597https://curecurrent.com/trials/combined-pneumococcal-conjugate-and-polysaccharide-vaccination-in-inflammatory-rheumatic-disease-101598https://curecurrent.com/trials/study-of-ati-450-plus-methotrexate-mtx-vs-mtx-alone-in-patients-with-moderate-to-severe-ra-101599https://curecurrent.com/trials/efficacy-of-jak-stat-pathways-inhibitors-in-treatment-of-patients-with-rheumatoid-arthritis-101600https://curecurrent.com/trials/skeletal-muscle-dysfunction-in-rheumatoid-arthritis-ra-101601https://curecurrent.com/trials/ultrasound-characteristics-of-the-salivary-glands-in-patients-with-rheumatoid-arthritis-101602https://curecurrent.com/trials/evaluating-the-effect-of-digoxin-and-ursodeoxycholic-acid-in-patients-with-rheumatoid-arthritis-101603https://curecurrent.com/trials/immunological-profile-and-microbial-markers-in-evaluating-the-effectiveness-of-probiotic-therapy-in-ra-patients-101604https://curecurrent.com/trials/physica-system-total-knee-replacement-registry-study-101605https://curecurrent.com/trials/covid-19-vaccine-in-immunosuppressed-adults-with-autoimmune-diseases-101606https://curecurrent.com/trials/effects-of-acupuncture-on-sj-gren-s-syndrome-101607https://curecurrent.com/trials/synovial-tissue-and-blood-signature-of-rheumatoid-arthritis-patients-with-disease-flare-after-treatment-discontinuation-101608https://curecurrent.com/trials/optimization-of-psoriatic-and-seronegative-rheumatoid-arthritis-patients-selection-and-treatment-outcomes-of-biologic-th-101609https://curecurrent.com/trials/improved-cardiovascular-health-for-patients-with-inflammatory-joint-diseases-101610https://curecurrent.com/trials/meditation-effects-on-brain-function-in-rheumatoid-arthritis-101611https://curecurrent.com/trials/jak-i-on-ra-b-lymphocytes-tolerance-and-disease-resolution-through-jak-signaling-in-rheumatoid-arthritis-101612https://curecurrent.com/trials/efficacy-and-safety-study-of-kn019-in-rheumatoid-arthritis-patients-with-an-inadequate-response-to-methotrexate-101613https://curecurrent.com/trials/the-effects-of-exercise-on-serum-bdnf-and-irisin-levels-in-patients-with-rheumatoid-arthritis-101614https://curecurrent.com/trials/osteoporosis-awareness-in-rheumatoid-arthritis-patients-101615https://curecurrent.com/trials/ps150-total-knee-arthroplasty-outcomes-registry-101616https://curecurrent.com/trials/safety-and-retention-rate-of-the-jak-and-tnf-inhibitors-in-rheumatoid-arthritis-a-real-life-experience-101617https://curecurrent.com/trials/randomized-controlled-clinical-outcomes-of-the-vanguard-xp-bicruciate-knee-system-101618https://curecurrent.com/trials/a-study-to-evaluate-usability-of-subcutaneous-auto-injector-of-ct-p47-in-patients-with-active-rheumatoid-arthritis-101619https://curecurrent.com/trials/study-of-two-doses-of-abx464-in-participants-with-moderate-to-severe-rheumatoid-arthritis-101620https://curecurrent.com/trials/c-gloves-the-effectiveness-of-compression-gloves-in-arthritis-101621https://curecurrent.com/trials/the-effects-of-nutritional-on-disease-activity-and-functional-status-in-ra-101622https://curecurrent.com/trials/evaluation-of-fibromyalgia-syndrome-and-its-effect-on-quality-of-life-in-rheumatoid-arthritis-101623https://curecurrent.com/trials/evaluation-of-the-effect-of-neuropathic-pain-on-quality-of-life-in-rheumatoid-arthritis-patients-101624https://curecurrent.com/trials/a-study-to-compare-upadacitinib-abt-494-to-placebo-in-adults-with-rheumatoid-arthritis-on-stable-dose-of-conventional-sy-101625https://curecurrent.com/trials/a-phase-3-study-of-ni-071-in-participants-with-rheumatoid-arthritis-radiance-101626https://curecurrent.com/trials/a-phase-2-study-to-evaluate-the-safety-and-efficacy-of-lou064-in-patients-with-moderate-to-severe-sj-gren-s-syndrome-101627https://curecurrent.com/trials/an-observational-study-to-evaluate-impact-of-crp-level-on-real-world-effectiveness-of-upadacitinib-as-monotherapy-or-in-101628https://curecurrent.com/trials/a-study-in-healthy-japanese-participants-to-evaluate-the-safety-and-pharmacokinetics-of-otilimab-101629https://curecurrent.com/trials/prospective-longitudinal-effects-of-intra-articular-corticosteroid-injection-on-synovial-fluid-oxygen-101630https://curecurrent.com/trials/a-time-to-cardiovascular-event-analysis-comparing-tocilizumab-to-other-biologics-in-patients-with-rheumatoid-arthritis-r-101631https://curecurrent.com/trials/national-observational-study-on-the-use-of-inflectra-an-infliximab-biosimilar-in-real-life-101632https://curecurrent.com/trials/rheumatoid-arthritis-disease-activity-and-sub-clinical-atherosclerosis-101633https://curecurrent.com/trials/interleukin-6-inhibitors-and-drug-drug-interactions-in-patients-with-rheumatoid-arthritis-101634https://curecurrent.com/trials/tacrolimus-plus-glucocorticoid-for-severe-thrombocytopenia-in-ss-101635https://curecurrent.com/trials/nutrition-in-rheumatic-diseases-101636https://curecurrent.com/trials/effects-of-insoles-in-patients-with-rheumatoid-arthritis-randomized-controlled-trial-101637https://curecurrent.com/trials/covid-19-vaccine-booster-in-immunocompromised-rheumatic-diseases-101638https://curecurrent.com/trials/orthopilot-elite-post-market-clinical-follow-up-101639https://curecurrent.com/trials/study-of-etanercept-monotherapy-vs-methotrexate-monotherapy-for-maintenance-of-rheumatoid-arthritis-remission-101640https://curecurrent.com/trials/tacrolimus-for-thrombocytopenia-in-ss-101641https://curecurrent.com/trials/investigation-of-immunological-and-pharmacological-factors-for-response-to-adalimumab-in-rheumatoid-arthritis-101642https://curecurrent.com/trials/deciphering-a-specific-signature-of-the-immunosenescence-induced-in-covid-19-patients-versus-rheumatoid-arthritis-patien-101643https://curecurrent.com/trials/differential-diagnosis-of-sj-gren-s-versus-non-sj-gren-s-dry-eye-101644https://curecurrent.com/trials/sj-gren-and-gynecologic-considerations-101645https://curecurrent.com/trials/cortisol-circadian-rhythm-in-patients-with-ra-101646https://curecurrent.com/trials/effect-of-moringa-leaf-extract-on-disease-activity-in-rheumatoid-arthritis-patients-101647https://curecurrent.com/trials/fibres-supplementation-in-rheumatoid-arthritis-101648https://curecurrent.com/trials/study-on-the-pharmacokinetic-effect-of-itraconazole-on-shr0302-tablets-in-healthy-subjects-101649https://curecurrent.com/trials/a-pharmacokinetic-study-to-evaluate-the-drug-interaction-between-shr0302-and-cyp-substrates-in-healthy-volunteers-101650https://curecurrent.com/trials/baff-var-as-a-biomarker-of-response-to-b-depletive-treatment-in-systemic-lupus-erythematosus-and-rheumatoid-arthritis-101651https://curecurrent.com/trials/post-market-clinical-follow-up-study-protocol-for-profemur-gladiator-cemented-femoral-stems-101652https://curecurrent.com/trials/novel-complex-radiodiagnostics-of-peripherial-arthropathies-101653https://curecurrent.com/trials/manual-lymphatic-drainage-for-rheumatoid-arthritis-101654https://curecurrent.com/trials/anifrolumab-treatment-for-24-weeks-in-patients-with-primary-sj-gren-s-syndrome-101655https://curecurrent.com/trials/one-or-two-week-methotrexate-discontinuation-on-efficacy-of-influenza-vaccination-in-rheumatoid-arthritis-101656https://curecurrent.com/trials/comparison-of-the-effects-of-aerobic-and-resistive-exercises-in-female-patients-with-rheumatoid-arthritis-101657https://curecurrent.com/trials/the-clinical-features-and-pregnancy-outcomes-of-ra-patients-101658https://curecurrent.com/trials/objective-measurement-with-tcm-pattern-for-aiddes-101659https://curecurrent.com/trials/isis-104838-an-inhibitor-of-tumor-necrosis-factor-for-active-rheumatoid-arthritis-101660https://curecurrent.com/trials/hrr-as-a-novel-biomarker-in-sj-gren-s-syndrome-101661https://curecurrent.com/trials/efficacy-and-safety-of-pirfenidone-in-ctd-ild-101662https://curecurrent.com/trials/the-clinical-efficacy-of-immunomodulators-in-ra-patients-101663https://curecurrent.com/trials/repeat-dose-subcutaneous-rhumatoid-arthritis-efficacy-study-101664https://curecurrent.com/trials/the-effects-of-cardiac-rehabilitation-on-cardiovascular-disease-risk-in-rheumatoid-arthritis-patients-101665https://curecurrent.com/trials/periodontal-therapy-in-patients-with-rheumatoid-arthritis-101666https://curecurrent.com/trials/to-compare-the-efficacy-and-safety-of-low-dose-glucocorticoids-and-tofacitinib-in-alleviating-moderate-to-high-disease-a-101667https://curecurrent.com/trials/clinical-study-of-magnetic-resonance-imaging-and-deep-learning-of-joint-synovial-disease-101668https://curecurrent.com/trials/effect-of-anti-inflammatory-itis-diet-in-rheumatoid-arthritis-101669https://curecurrent.com/trials/sjogren-s-lung-study-101670https://curecurrent.com/trials/treatments-against-ra-and-effect-on-fdg-pet-ct-101671https://curecurrent.com/trials/effectiveness-of-sms-reminders-on-influenza-vaccination-coverage-in-patients-with-ra-in-the-art-registry-101672https://curecurrent.com/trials/signature-acetabular-posterior-lateral-data-collection-101673https://curecurrent.com/trials/effectiveness-and-safety-of-yisaipu-combined-with-tripterygium-wilfordii-for-active-ra-101674https://curecurrent.com/trials/study-to-evaluate-the-safety-and-efficacy-of-ilv-094-in-subjects-with-rheumatoid-arthritis-101675https://curecurrent.com/trials/expression-of-irak1-gene-rs1059703-related-single-nucleotide-polymorphisms-in-egyptian-patient-with-rheumatoid-arthritis-101676https://curecurrent.com/trials/one-year-persistence-to-treatment-of-participants-receiving-flixabi-or-imraldi-a-french-cohort-study-101677https://curecurrent.com/trials/nir-fluorescence-imaging-of-lymphatic-transport-using-icg-101678https://curecurrent.com/trials/post-market-follow-up-study-of-the-evolution-total-knee-arthroplasty-system-with-cruciate-sacrificing-inserts-101679https://curecurrent.com/trials/effects-of-aromatherapy-on-pain-sleep-quality-and-psychological-distress-in-patients-with-rheumatoid-arthritis-101680https://curecurrent.com/trials/post-market-clinical-follow-up-study-protocol-for-profemur-l-revision-femoral-stems-101681https://curecurrent.com/trials/pelvic-floor-exercises-in-patients-with-sj-gren-s-101682https://curecurrent.com/trials/comparative-study-of-janus-kinase-jak-inhibitors-vs-tumor-necrosis-factor-tnf-inhibitors-in-rheumatoid-arthritis-101683https://curecurrent.com/trials/long-term-observational-study-to-evaluation-the-safety-of-furestem-ra-inj-k0202-101684https://curecurrent.com/trials/safety-and-efficacy-of-furestem-ra-inj-in-patients-with-moderate-to-severe-rheumatoid-arthritis-101685https://curecurrent.com/trials/relation-of-il23r-and-il17a-gene-polymorphisms-plus-serum-levels-of-il23-and-il17a-to-rheumatoid-arthritis-susceptibilit-101686https://curecurrent.com/trials/lung-disease-associated-with-rheumatoid-arthritis-101687https://curecurrent.com/trials/impact-of-a-hybrid-medical-care-model-in-the-rheumatoid-arthritis-patient-reported-outcomes-measures-101688https://curecurrent.com/trials/juvenile-rheumatoid-arthritis-research-registry-101689https://curecurrent.com/trials/impact-in-the-medical-care-among-the-rheumatic-diseases-patients-in-a-hospital-in-m-xico-during-covid-19-pandemic-101690https://curecurrent.com/trials/th17-responses-evaluated-in-ra-patients-on-inhibitors-of-tnf-101691https://curecurrent.com/trials/efficacy-and-safety-of-abatacept-combined-with-jak-inhibitor-for-refractory-rheumatoid-arthritis-101692https://curecurrent.com/trials/rheumatoid-arthritis-treatment-after-first-anti-tnf-investigation-101693https://curecurrent.com/trials/randomized-fixed-bearing-vs-mobile-bearing-cruciate-retaining-tka-101694https://curecurrent.com/trials/methotrexate-adherence-in-rheumatoid-arthritis-patients-101695https://curecurrent.com/trials/exploratory-study-on-safety-of-peek-knee-prosthesis-101696https://curecurrent.com/trials/lovastatin-for-the-treatment-of-mildly-active-rheumatoid-arthritis-101697https://curecurrent.com/trials/a-study-to-assess-the-safety-and-tolerability-of-lb-p6-and-lb-p8-in-healthy-participants-101698https://curecurrent.com/trials/prediction-of-methotrexate-response-a-pilot-study-101699https://curecurrent.com/trials/traditional-chinese-yijinjing-exercise-on-hand-dysfunction-in-rheumatoid-arthritis-patients-101700https://curecurrent.com/trials/kinesiotaping-applied-to-the-thumb-in-rheumatoid-hand-101701https://curecurrent.com/trials/the-norwegian-antirheumatic-drug-register-101702https://curecurrent.com/trials/biologic-national-registry-101703https://curecurrent.com/trials/effect-of-electroacupuncture-on-refractory-pain-in-juvenile-rheumatoid-arthritis-randomized-controlled-trial-101704https://curecurrent.com/trials/abatacept-to-silence-anti-citrullinated-protein-antibody-expressing-b-cells-in-rheumatoid-arthritis-ascara-101705https://curecurrent.com/trials/januse-kinase-inhibition-with-filgotinib-to-silence-autoreactive-b-cells-in-rheumatoid-arthritis-101706https://curecurrent.com/trials/accelerometry-in-follow-up-of-arthritis-a-pilot-study-101707https://curecurrent.com/trials/phase-ll-study-of-pirfenidone-in-patients-with-raild-trail1-101708https://curecurrent.com/trials/effects-of-kinesiotaping-for-hands-function-in-rheumatoid-arthritis-101709https://curecurrent.com/trials/dry-eye-syndrome-healthy-control-sj-gren-s-syndrome-and-other-inflammation-disease-in-taiwan-biobank-101710https://curecurrent.com/trials/ascension-pyrocarbon-radial-head-study-101711https://curecurrent.com/trials/determination-of-the-biological-activity-of-serum-from-patients-101712https://curecurrent.com/trials/a-study-of-tj003234-in-rheumatoid-arthritis-patients-101713https://curecurrent.com/trials/mon-tor-ng-glucocort-co-d-treatment-in-pat-ents-followed-in-rheumatology-cl-n-c-101714https://curecurrent.com/trials/vitamin-d-level-and-it-s-association-with-disease-activity-in-egyptian-rheumatoid-arthritis-patients-101715https://curecurrent.com/trials/2-year-post-approval-study-to-investigate-the-scandinavian-total-ankle-replacement-system-star-ankle-under-actual-condit-101716https://curecurrent.com/trials/a-new-mode-of-action-of-anti-tnf-reverse-signaling-in-rheumatoid-arthritis-101717https://curecurrent.com/trials/comparative-effectiveness-research-of-electroacupuncture-and-tens-in-patients-with-rheumatoid-arthritis-101718https://curecurrent.com/trials/clinical-study-comparing-two-implant-surface-finishes-in-patients-undergoing-cementless-total-hip-replacement-101719https://curecurrent.com/trials/a-study-evaluating-the-effects-of-glpg3970-given-as-an-oral-treatment-for-6-weeks-in-adults-with-moderately-to-severely-101720https://curecurrent.com/trials/pre-operative-rehabilitation-exercise-program-for-total-knee-arthroplasty-101721https://curecurrent.com/trials/randomized-controlled-rsa-study-comparing-the-taperloc-complete-versus-the-taperloc-complete-microplasty-101722https://curecurrent.com/trials/yoga-mindfulness-for-pain-management-in-inflammatory-arthritis-101723https://curecurrent.com/trials/gold-factor-on-knee-joint-health-and-function-101724https://curecurrent.com/trials/an-open-label-extension-study-evaluating-the-safety-and-efficacy-of-upadacitinib-abt-494-in-adults-with-rheumatoid-arthr-101725https://curecurrent.com/trials/real-world-effectiveness-of-adalimumab-on-health-outcomes-in-chinese-patients-with-immune-mediated-inflammatory-diseases-101726https://curecurrent.com/trials/dose-reduction-for-early-rheumatoid-arthritis-patients-with-low-disease-activity-101727https://curecurrent.com/trials/efficacy-and-safety-of-colquhounia-root-tablet-in-patients-with-rheumatoid-arthritis-101728https://curecurrent.com/trials/active-conventional-therapy-compared-to-three-different-biologic-treatments-in-early-rheumatoid-arthritis-with-subsequen-101729https://curecurrent.com/trials/pmcf-study-protocol-for-profemur-gladiator-plasma-femoral-stems-and-procotyl-l-beaded-acetabular-components-101730https://curecurrent.com/trials/study-to-compare-pk-safety-of-advixa-with-humira-in-healthy-adult-subject-followed-by-efficacy-safety-study-in-ra-patien-101731https://curecurrent.com/trials/the-value-of-orencia-in-rapidly-progressing-rheumatoid-arthritis-101732https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-amorphous-calcium-carbonate-in-ra-patient-with-osteopenia-or-osteoporosis-101733https://curecurrent.com/trials/a-study-of-human-substance-balance-and-biotransformation-of-14c-shr0302-101734https://curecurrent.com/trials/safety-of-tofacitinib-in-routine-care-patients-with-rheumatoid-arthritis-star-ra-cancer-endpoints-101735https://curecurrent.com/trials/assessment-of-galectin-9-in-rheumatoid-arthritis-and-its-correlation-with-disease-activity-101736https://curecurrent.com/trials/yuflyma-adalimumab-patient-experience-after-switching-101737https://curecurrent.com/trials/real-world-study-on-long-term-treatment-with-yisaipu-for-fujian-ra-patients-101738https://curecurrent.com/trials/safety-study-of-abatacept-in-sweden-101739https://curecurrent.com/trials/a-study-of-abatacept-in-participants-that-only-recently-started-to-develop-rheumatoid-arthritis-101740https://curecurrent.com/trials/study-to-evaluate-organic-anion-transporting-polypeptide-oatp-transporter-mediated-drug-drug-interactions-between-filgot-101741https://curecurrent.com/trials/survey-about-diet-in-chronic-inflammatory-rheumatic-diseases-101742https://curecurrent.com/trials/ultrasound-treatment-of-rheumatoid-arthritis-101743https://curecurrent.com/trials/a-physiotherapist-led-intervention-to-promote-physical-activity-in-rheumatoid-arthritis-a-pilot-study-101744https://curecurrent.com/trials/open-label-extension-study-of-cdp870-in-patients-with-rheumatoid-arthritis-101745https://curecurrent.com/trials/covid-19-vaccination-in-rheumatic-disease-patients-101746https://curecurrent.com/trials/screening-of-patients-with-rheumatoid-arthritis-for-interstitial-lung-disease-101747https://curecurrent.com/trials/olfactory-and-taste-disturbances-in-sjogren-s-syndrome-101748https://curecurrent.com/trials/prevalence-and-factors-of-sarcopenia-and-in-patients-with-primary-sjogren-s-syndrome-101749https://curecurrent.com/trials/cardiovascular-risk-and-chronic-inflammatory-rheumatism-101750https://curecurrent.com/trials/do-nanobubbles-improve-joint-hypoxia-101751https://curecurrent.com/trials/oral-cf101-tablets-treatment-in-patients-with-rheumatoid-arthritis-101752https://curecurrent.com/trials/rheumatoid-arthritis-and-treatment-of-periodontitis-a-randomized-clinical-trial-101753https://curecurrent.com/trials/early-rheumatoid-arthritis-cor-intervention-101754https://curecurrent.com/trials/biomarker-signature-and-musculoskeletal-ultrasound-profile-in-rheumatoid-arthritis-patients-101755https://curecurrent.com/trials/the-long-term-safety-and-efficacy-of-cdp6038-olokizumab-with-active-rheumatoid-arthritis-101756https://curecurrent.com/trials/ultrasound-assessment-of-rheumatoid-arthritis-patients-who-changed-diet-101757https://curecurrent.com/trials/rosa-total-knee-investigational-testing-authorization-study-101758https://curecurrent.com/trials/therapeutic-response-to-tumor-necrosis-factor-alpha-tnf-alpha-antagonists-in-rheumatoid-arthritis-101759https://curecurrent.com/trials/a-study-to-determine-the-risk-of-cancer-in-rheumatoid-arthritis-ra-patients-who-use-abatacept-and-other-biologic-agents-101760https://curecurrent.com/trials/study-to-evaluate-safety-tolerability-and-efficacy-of-gs-5718-in-participants-with-active-rheumatoid-arthritis-who-have-101761https://curecurrent.com/trials/a-study-to-investigate-the-safety-and-efficacy-of-emapalumab-an-anti-ifn-gamma-mab-in-patients-with-systemic-juvenile-id-101762https://curecurrent.com/trials/a-mediterranean-diet-in-rheumatoid-arthritis-101763https://curecurrent.com/trials/study-of-the-efficacy-and-safety-of-bcd-089-in-combination-with-methotrexate-in-patients-with-active-rheumatoid-arthriti-101764https://curecurrent.com/trials/virtual-reality-meditation-for-fatigue-101765https://curecurrent.com/trials/a-multicenter-study-to-compare-the-efficacy-and-safety-of-the-combination-of-etanercept-and-methotrexate-in-treatment-of-101766https://curecurrent.com/trials/anti-rheumatic-drug-use-and-risk-of-covid-19-infection-in-rheumatoid-arthritis-patients-101767https://curecurrent.com/trials/a-randomised-double-blind-phase-i-ii-study-to-evaluate-the-pk-pd-safety-and-efficacy-between-hlx01-and-rituximab-in-pati-101768https://curecurrent.com/trials/14-0-3-0-3-0-protein-with-rheumatoid-arthritis-101769https://curecurrent.com/trials/study-of-safety-and-efficacy-of-hlx01-mtx-in-patients-with-rheumatoid-arthritis-101770https://curecurrent.com/trials/factors-of-ild-in-newly-diagnosed-rheumatoid-arthritis-101771https://curecurrent.com/trials/registry-of-autoimmune-interstitial-lung-disease-101772https://curecurrent.com/trials/natrunix-versus-methotrexate-in-rheumatoid-arthritis-101773https://curecurrent.com/trials/effect-of-smoking-on-pain-and-atherosclerosis-in-patients-with-rheumatoid-arthritis-101774https://curecurrent.com/trials/effects-of-antirheumatic-treatment-on-levels-of-survivin-in-rheumatoid-arthritis-patients-101775https://curecurrent.com/trials/survivin-as-predictive-biomarker-for-ra-101776https://curecurrent.com/trials/effect-of-antiinflammatory-treatment-versus-hand-training-on-neuropsychiatric-comorbidity-in-ra-patients-101777https://curecurrent.com/trials/educational-intervention-to-improve-patient-physician-awareness-of-cardiovascular-risk-in-rheumatoid-arthritis-101778https://curecurrent.com/trials/post-market-clinical-follow-up-study-protocol-for-profemur-xm-femoral-stems-101779https://curecurrent.com/trials/novel-splinting-technique-using-3d-models-101780https://curecurrent.com/trials/effect-of-sarilumab-on-patient-reported-outcomes-in-patients-with-active-rheumatoid-arthritis-101781https://curecurrent.com/trials/the-attune-knee-outcome-study-101782https://curecurrent.com/trials/pharmacogenetic-studies-on-anti-il-6-receptor-monoclonal-antibodies-on-the-treatment-of-rheumatic-diseases-101783https://curecurrent.com/trials/assessing-withdrawal-of-disease-modifying-antirheumatic-drugs-in-rheumatoid-arthritis-101784https://curecurrent.com/trials/an-extension-study-in-participants-with-moderate-to-severe-rheumatoid-arthritis-101785https://curecurrent.com/trials/the-effect-of-an-anti-inflammatory-diet-in-patients-with-rheumatoid-arthritis-101786https://curecurrent.com/trials/omalizumab-for-lupus-101787https://curecurrent.com/trials/vaccination-perception-in-inflammatory-conditions-flu-pneumonia-and-covid-19-101788https://curecurrent.com/trials/open-label-study-to-assess-the-safety-and-efficacy-of-cdp6038-olokizumab-in-patients-who-completed-ra0056-101789https://curecurrent.com/trials/novel-form-of-acquired-long-qt-syndrome-101790https://curecurrent.com/trials/s-11-smr-tt-hybrid-glenoid-and-cementless-finned-short-stem-101791https://curecurrent.com/trials/polymyalgia-rheumatica-associated-to-primary-sjogren-syndrome-101792https://curecurrent.com/trials/incmnsz-rheumatoid-arthritis-cohort-101793https://curecurrent.com/trials/tolerance-and-effectiveness-of-cell-therapy-by-autologous-apoptotic-cells-in-the-treatment-of-rheumatoid-arthritis-101794https://curecurrent.com/trials/mtx-hold-during-covid-19-booster-101795https://curecurrent.com/trials/study-of-ce-224-535-a-twice-daily-pill-to-control-rheumatoid-arthritis-in-patients-who-have-not-totally-improved-with-me-101796https://curecurrent.com/trials/long-term-evaluation-of-sarilumab-in-rheumatoid-arthritis-patients-saril-ra-extend-101797https://curecurrent.com/trials/efficacy-and-safety-of-sarilumab-and-adalimumab-monotherapy-in-patients-with-rheumatoid-arthritis-saril-ra-monarch-101798https://curecurrent.com/trials/tripterygium-wilfordii-hook-f-and-methotrexate-for-postmenopausal-women-with-rheumatoid-arthritis-101799https://curecurrent.com/trials/outcomes-of-biological-therapy-on-rheumatoid-arthritis-101800https://curecurrent.com/trials/vaccination-against-sars-cov2-covid-19-in-chronic-inflammatory-rheumatism-and-factors-determining-its-decision-101801https://curecurrent.com/trials/clinical-study-of-single-dose-il-6r-mab-injection-in-ra-patients-101802https://curecurrent.com/trials/delivery-of-enhance-fitness-trial-101803https://curecurrent.com/trials/aerobic-exercise-program-followed-by-cold-water-immersion-effects-on-arthritis-patients-arterial-stiffness-101804https://curecurrent.com/trials/association-between-subtypes-of-anti-citrullinated-peptide-antibodies-and-lung-damage-in-rheumatoid-arthritis-101805https://curecurrent.com/trials/impact-of-anti-citrullinated-protein-antibody-status-on-treatment-response-and-treatment-persistence-in-participants-wit-101806https://curecurrent.com/trials/sacral-nerve-stimulation-for-mild-to-moderate-or-refractory-rheumatoid-arthritis-101807https://curecurrent.com/trials/the-effects-of-pilates-training-on-exercise-capacity-and-respiratory-muscle-performance-in-patients-with-rheumatoid-arth-101808https://curecurrent.com/trials/safety-of-tofacitinib-in-routine-care-patients-with-rheumatoid-arthritis-star-ra-cardiovascular-endpoints-101809https://curecurrent.com/trials/prevalence-of-anti-ccp-positivity-and-subclinical-signs-of-inflammation-in-patients-with-new-onset-of-non-specific-muscu-101810https://curecurrent.com/trials/safety-and-efficacy-of-amg-827-in-subjects-with-ra-101811https://curecurrent.com/trials/morbimortality-of-covid-19-in-patients-with-chronic-inflammatory-rheumatism-treated-with-immunosuppressants-101812https://curecurrent.com/trials/anti-inflammatory-diet-effect-in-rheumatoid-arthritis-patients-101813https://curecurrent.com/trials/tolerogenic-dendritic-cell-therapy-for-rheumatoid-arthritis-101814https://curecurrent.com/trials/a-study-to-evaluate-the-safety-of-an-investigational-drug-etoricoxib-in-patients-with-osteoarthritis-oa-or-rheumatoid-ar-101815https://curecurrent.com/trials/tetrandrine-in-the-treatment-of-rheumatoid-arthritis-101816https://curecurrent.com/trials/etoricoxib-prescribing-patterns-and-adverse-events-of-interest-in-primary-care-in-the-united-kingdom-mk-0663-162-am1-101817https://curecurrent.com/trials/adaptation-of-edaq-into-turkish-examining-the-reliability-and-validity-for-people-with-ra-101818https://curecurrent.com/trials/investigational-drug-versus-an-approved-drug-in-patients-with-rheumatoid-arthritis-0663-072-101819https://curecurrent.com/trials/pentacam-study-of-the-cornea-in-ra-patients-101820https://curecurrent.com/trials/role-of-vitamin-d3-supplementation-with-conventional-synthetic-disease-modifying-antirheumatic-drugs-csdmard-in-rheumato-101821https://curecurrent.com/trials/real-world-study-of-a-adalimumab-biosimilar-geleli-in-rheumatoid-arthritis-101822https://curecurrent.com/trials/cup-position-in-tha-with-standard-instruments-101823https://curecurrent.com/trials/china-rheumatoid-arthritis-registry-of-patients-with-chinese-medicine-101824https://curecurrent.com/trials/the-long-term-effectiveness-of-case-management-for-patients-with-rheumatoid-arthritis-in-taiwan-101825https://curecurrent.com/trials/rheumatoid-arthritis-dose-ranging-study-0663-086-completed-101826https://curecurrent.com/trials/effectiveness-of-therapeutic-fasting-and-specific-diet-in-patients-with-rheumatoid-arthritis-101827https://curecurrent.com/trials/purify-antigen-specific-b-cells-from-patients-with-rheumatoid-arthritis-101828https://curecurrent.com/trials/an-efficacy-and-safety-study-of-injectable-ravagalimab-to-assess-change-in-eular-sjogren-s-syndrome-disease-activity-ind-101829https://curecurrent.com/trials/a-phase-1-clinical-trial-to-evaluate-the-safety-and-pharmacokinetic-characteristics-of-dw1809-101830https://curecurrent.com/trials/a-phase-1-clinical-trial-to-evaluate-the-safety-and-pharmacokinetic-characteristics-of-dw1809-t2-101831https://curecurrent.com/trials/effects-of-a-rehabilitation-program-on-physical-performance-and-disease-self-management-in-rheumatoid-arthritis-101832https://curecurrent.com/trials/feasibility-of-a-cytokine-expression-profile-in-immune-cells-as-an-orientation-tool-in-therapeutic-decisions-for-auto-in-101833https://curecurrent.com/trials/health-promotion-and-wellness-program-for-adults-with-disabling-conditions-101834https://curecurrent.com/trials/real-world-effectiveness-of-abatacept-in-rheumatoid-arthritis-patients-a-prospective-single-arm-open-label-multi-center-101835https://curecurrent.com/trials/long-term-experience-with-abatacept-sc-in-routine-clinical-practice-101836https://curecurrent.com/trials/proprotein-convertase-subtilisin-kexin-9-in-rheumatoid-arthritis-101837https://curecurrent.com/trials/biosimilar-of-adalimumab-an-european-evaluation-101838https://curecurrent.com/trials/soluble-programmed-death-1-spd1-is-a-diagnostic-biomarker-of-ild-in-patients-with-rheumatoid-arthritis-disease-101839https://curecurrent.com/trials/effectiveness-of-an-exercise-program-and-education-through-a-mobile-application-for-the-management-of-patients-with-hand-101840https://curecurrent.com/trials/clinical-follow-up-of-anti-carbamylated-antibody-status-in-rheumatoid-arthritis-101841https://curecurrent.com/trials/vaccination-against-pneumococcal-in-na-ve-abatacept-rheumatoid-arthritis-patients-101842https://curecurrent.com/trials/effect-of-a-new-bi-specific-antibody-towards-dendritic-cells-on-inflammation-in-rheumatoid-arthritis-101843https://curecurrent.com/trials/clinical-and-dermoscopic-comparison-of-rheumatoid-arthritis-ankylosing-spondylitis-and-psoriasis-patients-nails-101844https://curecurrent.com/trials/brodalumab-amg-827-in-rheumatoid-arthritis-ra-participants-with-inadequate-response-to-methotrexate-101845https://curecurrent.com/trials/seroprevalence-study-of-cov-2-sars-covid-19-infection-in-patients-with-chronic-inflammatory-rheumatic-diseases-101846https://curecurrent.com/trials/a-multicenter-randomized-double-blind-placebo-controlled-study-of-the-combination-therapy-of-t-614-and-methotrexate-in-r-101847https://curecurrent.com/trials/pk-similarity-prospective-phase-3-study-in-patients-with-rheumatoid-arthritis-101848https://curecurrent.com/trials/clinical-trial-on-the-efficacy-of-raloxifene-on-disease-activity-in-rheumatoid-arthritis-101849https://curecurrent.com/trials/diagnostic-value-of-hand-ultrasound-in-assessment-of-rheumatoid-arthritis-101850https://curecurrent.com/trials/the-effect-of-deep-breathing-and-transcutaneus-electrical-nerve-stimulation-on-heart-rate-variability-101851https://curecurrent.com/trials/phase-1-single-and-multiple-dose-study-of-fpa008-in-healthy-volunteers-and-rheumatoid-arthritis-subjects-101852https://curecurrent.com/trials/early-changes-in-pain-disease-activity-and-ultrasound-evidence-of-inflammatory-synovitis-in-patients-receiving-jak-inhib-101853https://curecurrent.com/trials/discontinuation-of-methotrexate-in-rheumatoid-arthritis-patients-achieving-clinical-remission-by-treatment-with-upadacit-101854https://curecurrent.com/trials/phase-iib-rheumatoid-arthritis-dose-ranging-study-for-bms-945429-in-subjects-who-are-not-responding-to-methotrexate-101855https://curecurrent.com/trials/predictive-clinical-diagnosis-of-rheumatoid-arthritis-flares-using-non-invasive-infra-red-thermal-imaging-and-an-ai-ml-a-101856https://curecurrent.com/trials/study-to-evaluate-the-safety-pk-pd-and-efficacy-of-amg-827-in-adults-with-rheumatoid-arthritis-101857https://curecurrent.com/trials/data-analysis-for-drug-repurposing-for-effective-alzheimer-s-medicines-dream-methotrexate-vs-hydroxychloroquine-101858https://curecurrent.com/trials/data-analysis-for-drug-repurposing-for-effective-alzheimer-s-medicines-dream-tnfi-vs-abatacept-101859https://curecurrent.com/trials/safety-and-effectiveness-of-live-zoster-vaccine-in-anti-tumor-necrosis-factor-tnf-users-verve-trial-101860https://curecurrent.com/trials/investigate-the-safety-tolerability-and-pharmacokinetics-of-fbl-mtx-101861https://curecurrent.com/trials/to-evaluate-the-efficacy-and-safety-of-sunpharma1505-compared-with-reference1505-in-subjects-with-active-rheumatoid-arth-101862https://curecurrent.com/trials/the-bcd-089-ail6r-in-patients-with-active-rheumatoid-arthritis-101863https://curecurrent.com/trials/comparative-study-of-bat1806-to-roactemra-in-rheumatoid-arthritis-patients-with-inadequate-response-to-methotrexate-101864https://curecurrent.com/trials/comparative-study-to-evaluate-the-pharmacokinetics-of-bat1806-vs-actemra-in-healthy-subjects-101865https://curecurrent.com/trials/a-study-to-compare-efficacy-and-safety-of-ct-p17-with-humira-in-patients-with-active-rheumatoid-arthritis-101866https://curecurrent.com/trials/a-study-to-evaluate-usability-of-subcutaneous-auto-injector-of-ct-p17-in-patients-with-active-rheumatoid-arthritis-101867https://curecurrent.com/trials/persistence-of-biological-treatment-and-inhibitors-of-jak-kinases-in-patients-with-rheumatoid-arthritis-101868https://curecurrent.com/trials/data-analysis-for-drug-repurposing-for-effective-alzheimer-s-medicines-dream-tofacitinib-vs-abatacept-101869https://curecurrent.com/trials/feasibility-of-a-mobile-application-to-support-reflection-and-dialog-about-strengths-in-people-with-chronic-illness-101870https://curecurrent.com/trials/data-analysis-for-drug-repurposing-for-effective-alzheimer-s-medicines-dream-tocilizumab-vs-abatacept-101871https://curecurrent.com/trials/impact-of-photodynamic-therapy-as-an-adjunct-to-non-surgical-periodontal-treatment-on-clinical-and-biochemical-parameter-101872https://curecurrent.com/trials/screening-for-flare-after-b-tsdmard-discontinuation-in-rheumatoid-arthritis-101873https://curecurrent.com/trials/non-inferiority-of-reduced-dose-rituximab-in-rheumatoid-arthritis-in-low-disease-activity-and-remission-101874https://curecurrent.com/trials/evaluation-of-hand-functions-in-newly-diagnosed-primary-sj-gren-s-syndrome-101875https://curecurrent.com/trials/effectiveness-and-feasibility-of-a-home-based-exercise-program-for-adolescents-with-juvenile-idiopathic-arthritis-101876https://curecurrent.com/trials/efficacy-and-safety-of-selective-jak-1-inhibitor-filgotinib-in-active-rheumatoid-arthritis-patients-with-inadequate-resp-101877https://curecurrent.com/trials/assess-structural-damage-in-rheumatoid-arthritis-using-biomarkers-and-radiography-101878https://curecurrent.com/trials/ticagrelor-in-methotrexate-resistant-rheumatoid-arthritis-101879https://curecurrent.com/trials/efficacy-safety-and-tolerability-of-denosumab-in-the-treatment-of-rheumatoid-arthritis-101880https://curecurrent.com/trials/a-study-of-cd19-bcma-chimeric-antigen-receptor-t-cells-therapy-for-patients-with-refractory-sjogren-s-syndrome-101881https://curecurrent.com/trials/randomized-double-blind-vehicle-controlled-repeat-dose-comparative-study-in-ra-patients-managed-with-dmards-101882https://curecurrent.com/trials/therapeutic-strategy-associated-with-bdmards-or-tsdmards-in-rheumatoid-arthritis-and-psoriatic-arthritis-101883https://curecurrent.com/trials/il-6-as-a-biomarker-for-personalized-treatment-of-pr-101884https://curecurrent.com/trials/multi-centre-study-on-tess-v2-shoulder-system-101885https://curecurrent.com/trials/ss-inq-information-needs-questionnaire-in-sj-gren-s-syndrome-101886https://curecurrent.com/trials/the-study-of-infliximab-cmab008-and-remicade-in-healthy-subjects-to-compare-the-pk-and-safety-101887https://curecurrent.com/trials/precision-medicine-across-the-disease-continuum-to-prevent-and-treat-rheumatoid-arthritis-101888https://curecurrent.com/trials/a-study-of-the-ep4-antagonist-cr6086-in-combination-with-methotrexate-in-dmard-na-ve-patients-with-early-rheumatoid-arth-101889https://curecurrent.com/trials/tl011-in-severe-active-rheumatoid-arthritis-patients-101890https://curecurrent.com/trials/study-of-shr0302-tablets-shr0302-as-monotherapy-in-active-rheumatoid-arthritis-ra-patients-101891https://curecurrent.com/trials/mbsr-in-rheumatoid-arthritis-patients-with-controlled-disease-but-persistent-depressive-symptoms-101892https://curecurrent.com/trials/periodontal-treatment-in-rheumatoid-arthritis-patients-101893https://curecurrent.com/trials/real-world-emulation-of-the-swefot-trial-101894https://curecurrent.com/trials/multidisciplinary-team-care-in-rheumatoid-arthritis-101895https://curecurrent.com/trials/a-study-with-upadacitinib-abt-494-in-subjects-from-china-and-selected-countries-with-moderately-to-severely-active-rheum-101896https://curecurrent.com/trials/balanced-knee-system-clinical-protocol-for-irb-approval-101897https://curecurrent.com/trials/anti-tnf-agents-for-the-treatment-of-rheumatoid-arthritis-101898https://curecurrent.com/trials/examination-of-efficacy-and-safety-of-baricitinib-in-ra-patients-101899https://curecurrent.com/trials/to-examine-whether-or-not-the-primary-causes-of-oa-or-ra-might-be-bone-alterations-101900https://curecurrent.com/trials/pain-catastrophizing-and-routine-assessment-of-patient-index-data-3-rapid3-in-ten-categories-of-rheumatology-outpatients-101901https://curecurrent.com/trials/evaluation-of-the-condition-of-rheumatoid-arthritis-after-treatment-101902https://curecurrent.com/trials/usefulness-of-non-tnf-usage-in-ra-patients-101903https://curecurrent.com/trials/lessening-the-impact-of-fatigue-in-inflammatory-rheumatic-diseases-101904https://curecurrent.com/trials/a-study-in-rheumatoid-arthritis-patients-who-have-completed-a-preceding-study-with-abbv-105-given-alone-or-in-combinatio-101905https://curecurrent.com/trials/unsupported-upper-limb-exercise-test-in-rheumatoid-arthritis-101906https://curecurrent.com/trials/patients-with-co-occurrence-of-anca-vasculitis-and-sj-gren-syndrome-101907https://curecurrent.com/trials/to-compare-the-efficacy-pharmacokinetics-and-safety-between-ct-p13-and-china-approved-remicade-when-co-administered-with-101908https://curecurrent.com/trials/study-to-evaluate-the-response-to-enbrel-and-the-impact-of-rheumatoid-factor-rf-and-anti-cyclic-citrullinated-peptide-an-101909https://curecurrent.com/trials/confident-treatment-decisions-in-living-with-rheumatoid-arthritis-101910https://curecurrent.com/trials/acute-response-to-exercise-in-patients-with-rheumatoid-arthritis-101911https://curecurrent.com/trials/a-study-investigating-the-efficacy-and-safety-of-abt-494-given-with-methotrexate-in-subjects-with-rheumatoid-arthritis-w-101912https://curecurrent.com/trials/platelet-rich-plasma-prp-injection-for-the-treatment-of-severe-dry-eye-101913https://curecurrent.com/trials/lps-flex-porous-femoral-components-101914https://curecurrent.com/trials/a-phase-2-study-of-e6011-in-subjects-with-rheumatoid-arthritis-inadequately-responding-to-biologics-101915https://curecurrent.com/trials/an-oral-p38-inhibitor-investigating-safety-efficacy-and-pk-in-subjects-with-active-rheumatoid-arthritis-101916https://curecurrent.com/trials/safety-study-of-tofacitinib-versus-tumor-necrosis-factor-tnf-inhibitor-in-subjects-with-rheumatoid-arthritis-101917https://curecurrent.com/trials/does-sildenafil-improve-endothelial-dysfunction-in-rheumatoid-arthritis-101918https://curecurrent.com/trials/evaluating-safety-of-escalating-doses-of-tilmanocept-by-iv-injection-and-spect-imaging-in-subjects-with-and-without-ra-101919https://curecurrent.com/trials/beta-3-agonist-and-anti-muscarinic-agent-for-sjogren-s-syndrome-with-overactive-bladder-101920https://curecurrent.com/trials/corneal-nerve-structure-in-sjogren-s-101921https://curecurrent.com/trials/magnetotherapy-in-rheumatoid-arthritis-treatment-101922https://curecurrent.com/trials/rheumatism-and-dietetic-rhumadiet-study-food-practices-and-beliefs-101923https://curecurrent.com/trials/a-randomized-double-blind-placebo-controlled-parallel-group-multicenter-trial-to-evaluate-the-safety-tolerability-and-ef-101924https://curecurrent.com/trials/a-study-investigating-the-efficacy-and-safety-of-upadacitinib-abt-494-given-with-methotrexate-mtx-in-adults-with-rheumat-101925https://curecurrent.com/trials/interstitial-lung-diseases-in-primary-sjogren-s-syndrome-101926https://curecurrent.com/trials/lysophosphatidic-acid-autotaxin-axis-in-rheumatoid-lung-disease-101927https://curecurrent.com/trials/comparison-of-disease-modifying-antirheumatic-drugs-therapy-in-patients-with-ra-failing-methotrexate-monotherapy-101928https://curecurrent.com/trials/genicular-nerve-block-in-juvenile-idiopathic-arthritis-101929https://curecurrent.com/trials/the-role-of-microbiome-on-biological-therapy-efficacy-in-axspa-and-ra-101930https://curecurrent.com/trials/covid-19-infection-in-vulnerable-patients-with-inflammatory-rheumatic-diseases-101931https://curecurrent.com/trials/induction-of-regulatory-t-cells-by-low-dose-il2-in-autoimmune-and-inflammatory-diseases-101932https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-efficacy-of-abbv-3373-in-participants-with-moderate-to-101933https://curecurrent.com/trials/evaluation-of-the-safety-and-performance-of-the-freedom-total-knee-system-with-the-peek-optima-femoral-component-101934https://curecurrent.com/trials/diagnostic-value-of-hand-ultrasound-versus-mri-in-rheumatoid-arthritis-101935https://curecurrent.com/trials/long-term-efficacy-safety-and-tolerability-of-acz885-in-patients-with-rheumatoid-arthritis-101936https://curecurrent.com/trials/research-and-development-of-a-new-technology-for-detection-of-abnormal-excretion-of-intestinal-uric-acid-involved-in-the-101937https://curecurrent.com/trials/chronic-inflammatory-disease-lifestyle-and-treatment-response-101938https://curecurrent.com/trials/a-prospective-pilot-study-to-explore-efficacy-and-safety-of-baricitinib-in-active-primary-sjogren-s-syndrome-patients-101939https://curecurrent.com/trials/a-study-to-evaluate-efficacy-and-safety-of-anakinra-in-the-treatment-of-still-s-disease-sjia-and-aosd-101940https://curecurrent.com/trials/arthroscopic-synovectomy-combined-with-dmards-in-the-treatment-of-refractory-elbow-rheumatoid-arthritis-101941https://curecurrent.com/trials/effects-of-abatacept-in-patients-with-early-rheumatoid-arthritis-101942https://curecurrent.com/trials/genicular-nerve-block-in-rheuamtoid-arthritis-101943https://curecurrent.com/trials/vitamin-d-as-a-key-player-in-rheumatoid-arthritis-101944https://curecurrent.com/trials/prospective-maternal-surveillance-of-ssa-sj-gren-syndrome-a-positive-pregnancies-using-a-hand-held-fetal-heart-rate-moni-101945https://curecurrent.com/trials/assessment-of-14-3-3-eta-protein-antibodies-in-the-serum-of-rheumatoid-arthritis-patients-and-its-relation-to-atheroscle-101946https://curecurrent.com/trials/comparison-of-the-effect-of-etoricoxib-and-diclofenac-on-early-morning-activity-in-rheumatoid-arthritis-ra-101947https://curecurrent.com/trials/safety-and-efficacy-of-efavaleukin-alfa-in-subjects-with-active-rheumatoid-arthritis-101948https://curecurrent.com/trials/a-dose-response-study-of-e6011-in-participants-with-rheumatoid-arthritis-inadequately-responding-to-methotrexate-101949https://curecurrent.com/trials/c2013-0302-safety-and-efficacy-of-escalating-doses-of-san-300-in-patients-with-rheumatoid-arthritis-101950https://curecurrent.com/trials/a-nutrition-intervention-for-arthritis-2-101951https://curecurrent.com/trials/a-nutrition-intervention-for-arthritis-4-wccr-arth4-101952https://curecurrent.com/trials/safety-and-tolerability-pharmacokinetics-pk-pharmacodynamics-pd-and-efficacy-of-repeat-doses-of-gsk2982772-in-subjects-w-101953https://curecurrent.com/trials/the-role-of-tofacitinib-in-steroid-withdrawal-in-rheumatoid-arthritis-101954https://curecurrent.com/trials/study-to-evaluate-efficacy-safety-and-tolerability-of-jte-051-in-subjects-with-active-rheumatoid-arthritis-101955https://curecurrent.com/trials/research-protocol-for-karuna-labs-inc-safety-and-efficacy-of-virtual-reality-graded-motor-imagery-for-chronic-pain-101956https://curecurrent.com/trials/filgotinib-in-combination-with-methotrexate-in-adults-with-moderately-to-severely-active-rheumatoid-arthritis-who-have-a-101957https://curecurrent.com/trials/safety-and-efficacy-study-of-subcutaneous-belimumab-and-intravenous-rituximab-co-administration-in-subjects-with-primary-101958https://curecurrent.com/trials/exploratory-study-for-dry-mouth-in-patients-with-sj-gren-s-syndrome-101959https://curecurrent.com/trials/survey-of-cannabis-use-in-patients-with-chronic-inflammatory-arthritis-101960https://curecurrent.com/trials/comparative-analysis-of-outcomes-among-patients-treated-with-xeljanz-vs-biologics-101961https://curecurrent.com/trials/filgotinib-alone-and-in-combination-with-methotrexate-mtx-in-adults-with-moderately-to-severely-active-rheumatoid-arthri-101962https://curecurrent.com/trials/iadapt-third-phase-101963https://curecurrent.com/trials/avenir-m-ller-hip-stem-post-market-surveillance-study-101964https://curecurrent.com/trials/efficacy-and-safety-of-luo-fu-shan-plaster-in-patients-with-rheumatoid-arthritis-101965https://curecurrent.com/trials/compare-the-effect-of-eupatilin-and-rebamipide-on-the-prevention-of-gastroenteropathy-101966https://curecurrent.com/trials/filgotinib-versus-placebo-in-adults-with-active-rheumatoid-arthritis-ra-who-have-an-inadequate-response-to-biologic-dise-101967https://curecurrent.com/trials/effects-of-a-clinical-dietary-intervention-during-inpatient-treatment-101968https://curecurrent.com/trials/phase-iib-dose-ranging-study-in-subjects-with-moderate-to-severe-rheumatoid-arthritis-101969https://curecurrent.com/trials/sjogrens-syndrome-measured-by-ultrasound-101970https://curecurrent.com/trials/relationship-between-t-lymphocytes-depletion-and-clinical-response-to-rituximab-in-rheumatoid-arthritis-lyritux-101971https://curecurrent.com/trials/laser-acupuncture-in-rheumatoid-arthritis-geriatric-patients-101972https://curecurrent.com/trials/a-phase-2-study-to-evaluate-the-safety-and-efficacy-of-yra-1909-in-patients-with-rheumatoid-arthritis-101973https://curecurrent.com/trials/a-study-to-investigate-the-safety-and-efficacy-of-abbv-105-alone-or-in-combination-with-upadacitinib-abbv-599-combinatio-101974https://curecurrent.com/trials/assessment-of-the-clinical-and-medico-economic-impact-of-sinnotest-in-patients-with-rheumatoid-arthritis-101975https://curecurrent.com/trials/self-directed-exercise-program-for-adults-with-arthritis-101976https://curecurrent.com/trials/mindfulness-based-stress-reduction-in-rheumatic-diseases-101977https://curecurrent.com/trials/smartphone-mindfulness-meditation-for-patients-with-rheumatic-diseases-101978https://curecurrent.com/trials/ucb-cimzia-pregnancy-follow-up-study-101979https://curecurrent.com/trials/viveye-ocular-magnetic-neurostimulation-system-omns-for-the-management-of-severe-dry-eye-disease-101980https://curecurrent.com/trials/effect-of-education-in-rheumatoid-arthritis-101981https://curecurrent.com/trials/cognitive-behavioural-therapy-for-insomnia-on-sleep-in-rheumatoid-arthritis-101982https://curecurrent.com/trials/improved-ability-to-cope-with-everyday-life-through-a-person-centered-training-program-in-elderly-patients-with-rheumato-101983https://curecurrent.com/trials/pilot-feasibility-study-of-a-sj-gren-s-syndrome-self-management-app-101984https://curecurrent.com/trials/reducing-sedentary-time-in-rheumatoid-arthritis-the-take-a-stand-for-health-study-101985https://curecurrent.com/trials/study-of-adalimumab-to-lower-cardiovascular-risk-in-ra-patients-with-well-controlled-joint-disease-101986https://curecurrent.com/trials/can-4-weeks-of-exercise-program-change-quadriceps-architecture-in-patients-with-rheumatoid-arthritis-101987https://curecurrent.com/trials/maxera-large-cups-canada-101988https://curecurrent.com/trials/study-of-venous-endothelial-cells-in-rheumatoid-arthritis-101989https://curecurrent.com/trials/a-study-of-rslv-132-in-subjects-with-primary-sjogren-s-syndrome-101990https://curecurrent.com/trials/selection-of-patients-with-chronic-inflammatory-rheumatism-requiring-management-during-the-covid-19-pandemia-101991https://curecurrent.com/trials/panlar-s-latin-american-registry-of-rheumatic-patients-treated-with-jak-inhibitors-101992https://curecurrent.com/trials/mh004-topical-cream-in-healthy-adult-volunteers-and-participants-with-atopic-dermatitis-or-rheumatoid-arthritis-101993https://curecurrent.com/trials/thiopurine-induced-pancreatitis-in-ibd-patients-101994https://curecurrent.com/trials/a-double-blind-study-evaluating-duvelisib-in-subjects-with-moderate-to-severe-rheumatoid-arthritis-and-an-inadequate-res-101995https://curecurrent.com/trials/rheumatoid-arthritis-satisfaction-outcome-research-101996https://curecurrent.com/trials/post-market-study-of-the-3dknee-system-101997https://curecurrent.com/trials/a-study-comparing-lbal-to-humira-in-subjects-with-active-rheumatoid-arthritis-despite-methotrexate-therapy-101998https://curecurrent.com/trials/study-of-arthritis-and-related-conditions-101999https://curecurrent.com/trials/trinity-biolox-delta-coc-thr-multi-center-study-102000https://curecurrent.com/trials/the-norwegian-drug-monitoring-study-102001https://curecurrent.com/trials/impact-of-acute-and-chronic-inflammation-on-cytochromes-p450-activity-measured-with-dried-blood-spot-102002https://curecurrent.com/trials/low-dose-naltrexone-for-chronic-pain-from-arthritis-102003https://curecurrent.com/trials/prospective-randomized-evaluation-of-celecoxib-integrated-safety-vs-ibuprofen-or-naproxen-102004https://curecurrent.com/trials/study-of-celecoxib-or-diclofenac-and-omeprazole-for-gastrointestinal-gi-safety-in-high-gi-risk-patients-with-arthritis-102005